DNA-binding	O
and	O
transcriptional	O
regulatory	O
properties	O
of	O
hepatic	B-protein
leukemia	I-protein
factor	I-protein
(	O
HLF	B-protein
)	O
and	O
the	O
t	O
(	O
17	O
;	O
19	O
)	O
acute	B-protein
lymphoblastic	I-protein
leukemia	I-protein
chimera	I-protein
E2A-HLF	I-protein
.	O

The	O
t	B-DNA
(	I-DNA
17	I-DNA
;	I-DNA
19	I-DNA
)	I-DNA
translocation	O
in	O
acute	O
lymphoblastic	O
leukemias	O
results	O
in	O
creation	O
of	O
E2A-hepatic	B-protein
leukemia	I-protein
factor	I-protein
(	O
HLF	B-protein
)	O
chimeric	B-protein
proteins	I-protein
that	O
contain	O
the	O
DNA-binding	B-protein
and	I-protein
protein	I-protein
dimerization	I-protein
domains	I-protein
of	O
the	O
basic	B-protein
leucine	I-protein
zipper	I-protein
(	I-protein
bZIP	I-protein
)	I-protein
protein	I-protein
HLF	B-protein
fused	O
to	O
a	O
portion	O
of	O
E2A	B-protein
proteins	I-protein
with	O
transcriptional	O
activation	O
properties	O
.	O

An	O
in	O
vitro	O
binding	O
site	O
selection	O
procedure	O
was	O
used	O
to	O
determine	O
DNA	O
sequences	O
preferentially	O
bound	O
by	O
wild-type	B-protein
HLF	I-protein
and	O
chimeric	B-protein
E2A-HLF	I-protein
proteins	O
isolated	O
from	O
various	O
t	B-cell_line
(	I-cell_line
17	I-cell_line
;	I-cell_line
19	I-cell_line
)	I-cell_line
-bearing	I-cell_line
leukemias	I-cell_line
.	O

All	O
were	O
found	O
to	O
selectively	O
bind	O
the	O
consensus	B-DNA
sequence	I-DNA
5'-GTTACGTAAT-3	O
'	O
with	O
high	O
affinity	O
.	O

Wild-type	O
and	O
chimeric	B-protein
HLF	I-protein
proteins	I-protein
also	O
bound	O
closely	O
related	O
sites	O
identified	O
previously	O
for	O
bZIP	B-protein
proteins	I-protein
of	O
both	O
the	O
proline	B-protein
-and	O
acidic	O
amino	O
acid-rich	O
(	O
PAR	B-protein
)	O
and	O
C/EBP	B-protein
subfamilies	I-protein
;	O
however	O
,	O
E2A-HLF	B-protein
proteins	O
were	O
significantly	O
less	O
tolerant	O
of	O
certain	O
deviations	O
from	O
the	O
HLF	B-DNA
consensus	I-DNA
binding	I-DNA
site	I-DNA
.	O

These	O
differences	O
were	O
directly	O
attributable	O
to	O
loss	O
of	O
an	O
HLF	B-DNA
ancillary	I-DNA
DNA-binding	I-DNA
domain	I-DNA
in	O
all	O
E2A-HLF	B-protein
chimeras	I-protein
and	O
were	O
further	O
exacerbated	O
by	O
a	O
zipper	O
mutation	O
in	O
one	O
isolate	O
.	O

Both	O
wild-type	B-protein
and	O
chimeric	B-protein
HLF	I-protein
proteins	I-protein
displayed	O
transcriptional	B-protein
activator	I-protein
properties	O
in	O
lymphoid	B-cell_type
and	I-cell_type
nonlymphoid	I-cell_type
cells	I-cell_type
on	O
reporter	B-DNA
genes	I-DNA
containing	O
HLF	B-DNA
or	I-DNA
C/EBP	I-DNA
consensus	I-DNA
binding	I-DNA
sites	I-DNA
.	O

But	O
on	O
reporter	B-DNA
genes	I-DNA
with	O
nonoptimal	B-DNA
binding	I-DNA
sites	I-DNA
,	O
their	O
transcriptional	O
properties	O
diverged	O
and	O
E2A-HLF	B-protein
competitively	O
inhibited	O
activation	O
by	O
wild-type	B-protein
PAR	I-protein
proteins	I-protein
.	O

These	O
findings	O
establish	O
a	O
spectrum	O
of	O
binding	O
site-specific	O
transcriptional	O
properties	O
for	O
E2A-HLF	B-protein
which	O
may	O
preferentially	O
activate	O
expression	O
of	O
select	O
subordinate	O
genes	O
as	O
a	O
homodimer	O
and	O
potentially	O
antagonize	O
expression	O
of	O
others	O
through	O
heteromeric	O
interactions	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
Sept.	NULL
1994	NULL
,	NULL
p.	NULL
5986-5996	NULL
0270-7306/94/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

14	NULL
,	NULL
No	NULL
.	NULL

9	NULL
DNA-Binding	NULL
and	NULL
Transcriptional	NULL
Regulatory	NULL
Properties	NULL
of	NULL
Hepatic	NULL
Leukemia	NULL
Factor	NULL
(	NULL
HLF	NULL
)	NULL
and	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
Acute	NULL
Lymphoblastic	NULL
Leukemia	NULL
Chimera	NULL
E2A-HLF	NULL
STEPHEN	NULL
P.	NULL
HUNGER	NULL
,	NULL
ROXANE	NULL
BROWN	NULL
,	NULL
ano	NULL
MICHAEL	NULL
L.	NULL
CLEARY*	NULL
Laboratory	NULL
of	NULL
Experimental	NULL
Oncology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Stanford	NULL
,	NULL
California	NULL
94305	NULL
Received	NULL
27	NULL
January	NULL
1994/Returned	NULL
for	NULL
modification	NULL
24	NULL
March	NULL
1994/Accepted	NULL
6	NULL
June	NULL
1994	NULL
The	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemias	NULL
results	NULL
in	NULL
creation	NULL
of	NULL
E2A-hepatic	NULL
leukemia	NULL
factor	NULL
(	NULL
HLF	NULL
)	NULL
chimeric	NULL
proteins	NULL
that	NULL
contain	NULL
the	NULL
DNA-binding	NULL
and	NULL
protein	NULL
dimerization	NULL
domains	NULL
of	NULL
the	NULL
basic	NULL
leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
protein	NULL
HLF	NULL
fused	NULL
to	NULL
a	NULL
portion	NULL
of	NULL
E2A	NULL
proteins	NULL
with	NULL
transcriptional	NULL
activation	NULL
properties	NULL
.	NULL

An	NULL
in	NULL
vitro	NULL
binding	NULL
site	NULL
selection	NULL
procedure	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
DNA	NULL
sequences	NULL
preferentially	NULL
bound	NULL
by	NULL
wild-type	NULL
HLF	NULL
and	NULL
chimeric	NULL
E2A-HLF	NULL
proteins	NULL
isolated	NULL
from	NULL
various	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-bearing	NULL
leukemias	NULL
.	NULL

All	NULL
were	NULL
found	NULL
to	NULL
selectively	NULL
bind	NULL
the	NULL
consensus	NULL
sequence	NULL
5-GTTACGTAAT-3	NULL
'	NULL
with	NULL
high	NULL
affinity	NULL
.	NULL

Wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
also	NULL
bound	NULL
closely	NULL
related	NULL
sites	NULL
identified	NULL
previously	NULL
for	NULL
bZIP	NULL
proteins	NULL
of	NULL
both	NULL
the	NULL
proline-	NULL
and	NULL
acidic	NULL
amino	NULL
acid-rich	NULL
(	NULL
PAR	NULL
)	NULL
and	NULL
C/EBP	NULL
subfamilies	NULL
;	NULL
however	NULL
,	NULL
E2A-HLF	NULL
proteins	NULL
were	NULL
significantly	NULL
less	NULL
tolerant	NULL
of	NULL
certain	NULL
deviations	NULL
from	NULL
the	NULL
HLF	NULL
consensus	NULL
binding	NULL
site	NULL
.	NULL

These	NULL
differences	NULL
were	NULL
directly	NULL
attributable	NULL
to	NULL
loss	NULL
of	NULL
an	NULL
HLF	NULL
ancillary	NULL
DNA-binding	NULL
domain	NULL
in	NULL
all	NULL
E2A-HLF	NULL
chimeras	NULL
and	NULL
were	NULL
further	NULL
exacerbated	NULL
by	NULL
a	NULL
zipper	NULL
mutation	NULL
in	NULL
one	NULL
isolate	NULL
.	NULL

Both	NULL
wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
displayed	NULL
transcriptional	NULL
activator	NULL
properties	NULL
in	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
on	NULL
reporter	NULL
genes	NULL
containing	NULL
HLF	NULL
or	NULL
C/EBP	NULL
consensus	NULL
binding	NULL
sites	NULL
.	NULL

But	NULL
on	NULL
reporter	NULL
genes	NULL
with	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
,	NULL
their	NULL
transcriptional	NULL
properties	NULL
diverged	NULL
and	NULL
E2A-HLF	NULL
competitively	NULL
inhibited	NULL
activation	NULL
by	NULL
wild-type	NULL
PAR	NULL
proteins	NULL
.	NULL

These	NULL
findings	NULL
establish	NULL
a	NULL
spectrum	NULL
of	NULL
binding	NULL
site-specific	NULL
transcriptional	NULL
properties	NULL
for	NULL
E2A-HLF	NULL
which	NULL
may	NULL
preferentially	NULL
activate	NULL
expression	NULL
of	NULL
select	NULL
subordinate	NULL
genes	NULL
as	NULL
a	NULL
homodimer	NULL
and	NULL
potentially	NULL
antagonize	NULL
expression	NULL
of	NULL
others	NULL
through	NULL
heteromeric	NULL
interactions	NULL
.	NULL

Homeostatic	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
at	NULL
the	NULL
level	NULL
of	NULL
mRNA	NULL
transcription	NULL
is	NULL
essential	NULL
for	NULL
normal	NULL
cellular	NULL
growth	NULL
and	NULL
differentiation	NULL
(	NULL
37	NULL
)	NULL
.	NULL

A	NULL
remarkably	NULL
wide	NULL
range	NULL
of	NULL
diverse	NULL
cellular	NULL
proteins	NULL
known	NULL
as	NULL
transcription	NULL
factors	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
this	NULL
process	NULL
.	NULL

One	NULL
major	NULL
subfamily	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
the	NULL
basic	NULL
leucine	NULL
zipper	NULL
(	NULL
bZIP	NULL
)	NULL
proteins	NULL
,	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
highly	NULL
charged	NULL
basic	NULL
region	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
an	NULL
adjacent	NULL
amphipathic	NULL
a	NULL
helical	NULL
domain	NULL
termed	NULL
the	NULL
leucine	NULL
zipper	NULL
that	NULL
mediates	NULL
protein	NULL
dimerization	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
playing	NULL
important	NULL
roles	NULL
in	NULL
control	NULL
of	NULL
normal	NULL
growth	NULL
and	NULL
differentiation	NULL
,	NULL
specific	NULL
bZIP	NULL
proteins	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
malignant	NULL
transformation	NULL
.	NULL

Fos	NULL
and	NULL
Jun	NULL
,	NULL
which	NULL
heterodimerize	NULL
to	NULL
form	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
,	NULL
were	NULL
originally	NULL
identified	NULL
as	NULL
oncogenes	NULL
trans-duced	NULL
by	NULL
transforming	NULL
retroviruses	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
10	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
chicken	NULL
homolog	NULL
of	NULL
C/EBPB	NULL
,	NULL
NF-M	NULL
,	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
development	NULL
of	NULL
avian	NULL
myelogeneous	NULL
leukemia	NULL
(	NULL
5	NULL
,	NULL
20	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
chromosomal	NULL
translocations	NULL
in	NULL
acute	NULL
leukemias	NULL
(	NULL
6	NULL
)	NULL
and	NULL
solid	NULL
tumors	NULL
(	NULL
3	NULL
,	NULL
9	NULL
,	NULL
24	NULL
,	NULL
31	NULL
,	NULL
38	NULL
)	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
oncogenically	NULL
activate	NULL
various	NULL
transcriptional	NULL
proteins	NULL
,	NULL
including	NULL
members	NULL
of	NULL
the	NULL
bZIP	NULL
family	NULL
.	NULL

For	NULL
example	NULL
,	NULL
in	NULL
human	NULL
myxoid	NULL
liposarcoma	NULL
,	NULL
the	NULL
t	NULL
(	NULL
12	NULL
;	NULL
16	NULL
)	NULL
translocation	NULL
creates	NULL
a	NULL
protein	NULL
chimera	NULL
composed	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
C/EBP-like	NULL
protein	NULL
CHOP	NULL
fused	NULL
to	NULL
a	NULL
portion	NULL
of	NULL
a	NULL
novel	NULL
protein	NULL
referred	NULL
to	NULL
as	NULL
TLS	NULL
(	NULL
9	NULL
)	NULL
or	NULL
FUS	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Another	NULL
translocation	NULL
in	NULL
human	NULL
cancer	NULL
,	NULL
t	NULL
(	NULL
12	NULL
;	NULL
22	NULL
)	NULL
in	NULL
malignant	NULL
melanoma	NULL
of	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Experimental	NULL
Oncology	NULL
,	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
300	NULL
Pasteur	NULL
Dr.	NULL
,	NULL
Stanford	NULL
,	NULL
CA	NULL
94305	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
415	NULL
)	NULL
723-5471	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
415	NULL
)	NULL
725-6902	NULL
.	NULL

5986	NULL
soft	NULL
parts	NULL
,	NULL
fuses	NULL
the	NULL
ATF-1	NULL
gene	NULL
to	NULL
EWS	NULL
,	NULL
which	NULL
was	NULL
previously	NULL
identified	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
involvement	NULL
in	NULL
the	NULL
t	NULL
(	NULL
11	NULL
;	NULL
22	NULL
)	NULL
translocation	NULL
in	NULL
Ewing	NULL
's	NULL
sarcoma	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
structural	NULL
alterations	NULL
of	NULL
bZIP	NULL
proteins	NULL
are	NULL
a	NULL
recurring	NULL
theme	NULL
in	NULL
oncogenesis	NULL
;	NULL
however	NULL
,	NULL
the	NULL
effects	NULL
on	NULL
their	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
remain	NULL
undefined	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
reported	NULL
that	NULL
a	NULL
chimeric	NULL
bZIP	NULL
protein	NULL
called	NULL
EZ2A-hepatic	NULL
leukemia	NULL
factor	NULL
(	NULL
HLF	NULL
)	NULL
is	NULL
created	NULL
by	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q21-q22	NULL
;	NULL
p13	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
ALL	NULL
)	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

E2A-HLF	NULL
chimeras	NULL
consist	NULL
of	NULL
the	NULL
amino-terminal	NULL
two-thirds	NULL
of	NULL
E2A	NULL
proteins	NULL
,	NULL
including	NULL
two	NULL
regions	NULL
with	NULL
transcriptional	NULL
activation	NULL
properties	NULL
(	NULL
2	NULL
,	NULL
30	NULL
)	NULL
,	NULL
fused	NULL
to	NULL
the	NULL
DNA-binding	NULL
and	NULL
dimerization	NULL
domains	NULL
of	NULL
HLF	NULL
,	NULL
a	NULL
previously	NULL
unknown	NULL
bZIP	NULL
protein	NULL
.	NULL

HLF	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
closely	NULL
related	NULL
to	NULL
bZIP	NULL
proteins	NULL
DBP	NULL
(	NULL
27	NULL
)	NULL
and	NULL
TEF/VBP	NULL
(	NULL
11	NULL
,	NULL
17	NULL
)	NULL
,	NULL
which	NULL
comprise	NULL
a	NULL
distinct	NULL
subgroup	NULL
(	NULL
the	NULL
proline-	NULL
and	NULL
acidic	NULL
amino	NULL
acid-rich	NULL
[	NULL
PAR	NULL
]	NULL
subfamily	NULL
)	NULL
distinguished	NULL
both	NULL
structurally	NULL
and	NULL
functionally	NULL
from	NULL
the	NULL
larger	NULL
bZIP	NULL
protein	NULL
superfamily	NULL
(	NULL
11	NULL
)	NULL
.	NULL

These	NULL
characteristic	NULL
bZIP	NULL
proteins	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
genes	NULL
that	NULL
display	NULL
a	NULL
tissue-restricted	NULL
or	NULL
developmental	NULL
stage-specific	NULL
expression	NULL
profile	NULL
,	NULL
particularly	NULL
in	NULL
mature	NULL
hepatocytes	NULL
(	NULL
DBP	NULL
and	NULL
VBP	NULL
)	NULL
or	NULL
developing	NULL
thyrotrophs	NULL
(	NULL
TEF	NULL
)	NULL
in	NULL
the	NULL
embryonic	NULL
pituitary	NULL
(	NULL
11	NULL
,	NULL
17	NULL
,	NULL
21	NULL
,	NULL
27	NULL
,	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
PAR	NULL
and	NULL
several	NULL
other	NULL
bZIP	NULL
proteins	NULL
,	NULL
HLF	NULL
expression	NULL
is	NULL
restricted	NULL
in	NULL
adult	NULL
and	NULL
fetal	NULL
tissues	NULL
(	NULL
primar-ily	NULL
liver	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
lung	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
also	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
cell-type-specific	NULL
transcription	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
HLF	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
normal	NULL
or	NULL
malignant	NULL
hematolymphoid	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
its	NULL
redirected	NULL
expression	NULL
by	NULL
chromosomal	NULL
translocations	NULL
in	NULL
immature	NULL
lymphoid	NULL
cells	NULL
is	NULL
an	NULL
important	NULL
pathoge-netic	NULL
event	NULL
.	NULL

In	NULL
earlier	NULL
studies	NULL
,	NULL
wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
were	NULL
VoL	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
demonstrated	NULL
to	NULL
cross-bind	NULL
to	NULL
a	NULL
TEF	NULL
recognition	NULL
site	NULL
present	NULL
in	NULL
the	NULL
rat	NULL
growth	NULL
hormone	NULL
(	NULL
GH	NULL
)	NULL
promoter	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
observed	NULL
as	NULL
homodimers	NULL
or	NULL
heterodimeric	NULL
complexes	NULL
with	NULL
the	NULL
related	NULL
PAR	NULL
proteins	NULL
DBP	NULL
and	NULL
TEF	NULL
.	NULL

It	NULL
was	NULL
noted	NULL
that	NULL
DNA	NULL
binding	NULL
to	NULL
the	NULL
TEF	NULL
GH	NULL
site	NULL
was	NULL
measurably	NULL
poorer	NULL
by	NULL
E2A-HLF	NULL
compared	NULL
with	NULL
wild-type	NULL
HLF	NULL
,	NULL
and	NULL
a	NULL
zipper	NULL
mutation	NULL
in	NULL
EZA-HLF	NULL
further	NULL
exacerbated	NULL
this	NULL
difference	NULL
.	NULL

Since	NULL
DNA	NULL
binding	NULL
by	NULL
E2A-HLF	NULL
heterodimers	NULL
was	NULL
less	NULL
impaired	NULL
,	NULL
these	NULL
findings	NULL
suggested	NULL
the	NULL
intriguing	NULL
possibility	NULL
that	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
could	NULL
participate	NULL
in	NULL
heterodimeric	NULL
interactions	NULL
with	NULL
other	NULL
bZIP	NULL
proteins	NULL
in	NULL
addition	NULL
to	NULL
a	NULL
potential	NULL
role	NULL
as	NULL
homodimeric	NULL
transcription	NULL
factors	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
the	NULL
chimeric	NULL
products	NULL
from	NULL
additional	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-ALLs	NULL
have	NULL
been	NULL
characterized	NULL
(	NULL
13	NULL
,	NULL
16	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
show	NULL
that	NULL
all	NULL
E2A-HLF	NULL
chimeras	NULL
include	NULL
the	NULL
same	NULL
portion	NULL
of	NULL
HLF	NULL
containing	NULL
its	NULL
basic	NULL
and	NULL
leucine	NULL
zipper	NULL
motifs	NULL
and	NULL
that	NULL
somatic	NULL
mutations	NULL
of	NULL
the	NULL
zipper	NULL
are	NULL
not	NULL
a	NULL
general	NULL
feature	NULL
.	NULL

However	NULL
,	NULL
amino	NULL
acids	NULL
juxtaposed	NULL
with	NULL
the	NULL
HLF	NULL
basic	NULL
region	NULL
,	NULL
either	NULL
from	NULL
EZ2A	NULL
or	NULL
from	NULL
random	NULL
insertions	NULL
of	NULL
nontemplated	NULL
nucleotides	NULL
,	NULL
can	NULL
vary	NULL
from	NULL
one	NULL
leukemia	NULL
to	NULL
another	NULL
because	NULL
of	NULL
diverse	NULL
genomic	NULL
rearrangements	NULL
underlying	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
.	NULL

The	NULL
variable	NULL
structural	NULL
features	NULL
of	NULL
different	NULL
E2A-HLF	NULL
chimeras	NULL
suggested	NULL
that	NULL
their	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
properties	NULL
might	NULL
be	NULL
heterogeneous	NULL
,	NULL
particularly	NULL
since	NULL
the	NULL
sites	NULL
of	NULL
protein	NULL
fusion	NULL
occurred	NULL
within	NULL
or	NULL
adjacent	NULL
to	NULL
the	NULL
regions	NULL
implicated	NULL
in	NULL
protein-DNA	NULL
interactions	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
basic	NULL
region	NULL
)	NULL
.	NULL

The	NULL
current	NULL
studies	NULL
were	NULL
undertaken	NULL
to	NULL
further	NULL
characterize	NULL
and	NULL
establish	NULL
the	NULL
structural	NULL
basis	NULL
for	NULL
differences	NULL
observed	NULL
previously	NULL
in	NULL
the	NULL
DNA-binding	NULL
capability	NULL
of	NULL
E2A-HLF	NULL
and	NULL
to	NULL
establish	NULL
their	NULL
potential	NULL
role	NULL
in	NULL
determining	NULL
or	NULL
restricting	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
the	NULL
chimeric	NULL
proteins	NULL
.	NULL

Using	NULL
an	NULL
in	NULL
vitro	NULL
binding	NULL
site	NULL
selection	NULL
assay	NULL
,	NULL
we	NULL
identified	NULL
an	NULL
identical	NULL
dyad	NULL
symmetric	NULL
core	NULL
consensus	NULL
sequence	NULL
to	NULL
which	NULL
both	NULL
HLF	NULL
and	NULL
various	NULL
E2A-HLF	NULL
chimeras	NULL
bound	NULL
avidly	NULL
.	NULL

HLF	NULL
and	NULL
E2A-HLF	NULL
also	NULL
bound	NULL
well	NULL
to	NULL
closely	NULL
related	NULL
sites	NULL
,	NULL
but	NULL
altered	NULL
binding	NULL
to	NULL
certain	NULL
divergent	NULL
sites	NULL
was	NULL
a	NULL
consistent	NULL
feature	NULL
of	NULL
E2A-HLF	NULL
proteins	NULL
and	NULL
was	NULL
directly	NULL
attributable	NULL
to	NULL
loss	NULL
of	NULL
an	NULL
HLF	NULL
ancillary	NULL
DNA-binding	NULL
domain	NULL
.	NULL

In	NULL
both	NULL
lymphoid	NULL
and	NULL
nonlymphoid	NULL
cells	NULL
,	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
functioned	NULL
experimentally	NULL
as	NULL
transcriptional	NULL
activators	NULL
of	NULL
reporter	NULL
genes	NULL
containing	NULL
a	NULL
minimal	NULL
promoter	NULL
with	NULL
adjacent	NULL
HLF	NULL
consensus	NULL
binding	NULL
sites	NULL
or	NULL
high	NULL
affinity	NULL
C/EBP	NULL
sites	NULL
,	NULL
although	NULL
their	NULL
transcriptional	NULL
properties	NULL
diverged	NULL
on	NULL
reporters	NULL
containing	NULL
less-optimal	NULL
sites	NULL
.	NULL

Thus	NULL
,	NULL
despite	NULL
their	NULL
altered	NULL
DNA-binding	NULL
properties	NULL
,	NULL
chimeric	NULL
E2A-HLF	NULL
proteins	NULL
can	NULL
function	NULL
as	NULL
transcriptional	NULL
activators	NULL
whose	NULL
leukemogenic	NULL
properties	NULL
are	NULL
likely	NULL
mediated	NULL
by	NULL
dys-regulation	NULL
of	NULL
target	NULL
genes	NULL
normally	NULL
regulated	NULL
by	NULL
related	NULL
bZIP	NULL
proteins	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
EMSAs	NULL
and	NULL
consensus	NULL
binding	NULL
site	NULL
selection	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
with	NULL
proteins	NULL
translated	NULL
in	NULL
vitro	NULL
(	NULL
IVT	NULL
)	NULL
from	NULL
expression	NULL
plasmids	NULL
,	NULL
using	NULL
a	NULL
coupled	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
translates	NULL
from	NULL
reactions	NULL
programmed	NULL
with	NULL
vector	NULL
(	NULL
pSP64	NULL
)	NULL
alone	NULL
served	NULL
as	NULL
negative	NULL
controls	NULL
for	NULL
EMSA	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
approximately	NULL
equal	NULL
amounts	NULL
of	NULL
IVT	NULL
protein	NULL
were	NULL
present	NULL
in	NULL
binding	NULL
reaction	NULL
mixtures	NULL
,	NULL
1/10	NULL
of	NULL
each	NULL
reaction	NULL
mixture	NULL
was	NULL
translated	NULL
in	NULL
parallel	NULL
with	NULL
[	NULL
°°SJmethionine	NULL
.	NULL

Labelled	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
and	NULL
quantitated	NULL
on	NULL
a	NULL
phosphoimager	NULL
,	NULL
and	NULL
values	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
number	NULL
of	NULL
methionine	NULL
residues	NULL
;	NULL
these	NULL
results	NULL
were	NULL
used	NULL
to	NULL
standardize	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
unlabelled	NULL
translation	NULL
mixtures	NULL
added	NULL
to	NULL
each	NULL
binding	NULL
reaction	NULL
TRANSCRIPTIONAL	NULL
REGULATORY	NULL
PROPERTIES	NULL
OF	NULL
E2A-HLF	NULL
5987	NULL
mixture	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
all	NULL
binding	NULL
sites	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
for	NULL
sequences	NULL
)	NULL
shared	NULL
an	NULL
identical	NULL
backbone	NULL
derived	NULL
from	NULL
the	NULL
VBP	NULL
site	NULL
in	NULL
the	NULL
chicken	NULL
vitellogenin	NULL
II	NULL
(	NULL
VTG	NULL
II	NULL
)	NULL
promoter	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Single-stranded	NULL
oligonucleotides	NULL
CAAAAAGAGGAGT	NULL
(	NULL
®	NULL
)	NULL
,	NULL
,	NULL
CCTGATAAAAAAG-3	NULL
'	NULL
and	NULL
5'-GATCCTTTTITTATCAGG	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
ACTCCTCTTTTTGA-3	NULL
'	NULL
,	NULL
where	NULL
X	NULL
and	NULL
Y	NULL
represent	NULL
complementary	NULL
nucleotides	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
of	NULL
interest	NULL
]	NULL
were	NULL
annealed	NULL
and	NULL
labelled	NULL
by	NULL
Klenow	NULL
fill-in	NULL
.	NULL

For	NULL
several	NULL
nondyad	NULL
symmetric	NULL
sites	NULL
the	NULL
10-nucleotide	NULL
binding	NULL
site	NULL
core	NULL
was	NULL
analyzed	NULL
in	NULL
both	NULL
orientations	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
backbone	NULL
;	NULL
no	NULL
differences	NULL
in	NULL
binding	NULL
were	NULL
observed	NULL
.	NULL

A	NULL
modification	NULL
of	NULL
the	NULL
selective	NULL
amplification	NULL
and	NULL
binding	NULL
(	NULL
SAAB	NULL
)	NULL
assay	NULL
(	NULL
4	NULL
)	NULL
was	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
consensus	NULL
HLF	NULL
binding	NULL
site	NULL
.	NULL

A	NULL
single-stranded	NULL
oligonucleotide	NULL
containing	NULL
20	NULL
internal	NULL
degenerate	NULL
positions	NULL
[	NULL
STI	NULL
,	NULL
5-GAGGATCCAGTC	NULL
AGCATG-	NULL
(	NULL
N	NULL
)	NULL
;	NULL
,	NULL
-CTCAGCCTCGAGATCTCG-3	NULL
'	NULL
]	NULL
was	NULL
annealed	NULL
to	NULL
an	NULL
oligonucleotide	NULL
primer	NULL
complementary	NULL
to	NULL
the	NULL
3	NULL
'	NULL
arm	NULL
(	NULL
STI-D	NULL
,	NULL
5-CGAGATCTCGAGGCTGAG-3	NULL
'	NULL
)	NULL
and	NULL
converted	NULL
to	NULL
double-stranded	NULL
DNA	NULL
with	NULL
unlabelled	NULL
nucleotides	NULL
.	NULL

The	NULL
resultant	NULL
double-stranded	NULL
STI	NULL
DNA	NULL
was	NULL
end	NULL
labelled	NULL
with	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
,	NULL
and	NULL
0.15	NULL
nmol	NULL
was	NULL
used	NULL
in	NULL
binding	NULL
reactions	NULL
with	NULL
IVT	NULL
HLF	NULL
.	NULL

A	NULL
faint	NULL
shifted	NULL
complex	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
HLF	NULL
binding	NULL
reaction	NULL
but	NULL
not	NULL
in	NULL
the	NULL
negative	NULL
control	NULL
IVT	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
area	NULL
of	NULL
the	NULL
gel	NULL
corresponding	NULL
to	NULL
this	NULL
complex	NULL
was	NULL
excised	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
was	NULL
eluted	NULL
in	NULL
H	NULL
,	NULL
O	NULL
.	NULL

Approximately	NULL
10	NULL
%	NULL
of	NULL
the	NULL
eluate	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
ST1-D	NULL
and	NULL
an	NULL
oligomer	NULL
homologous	NULL
to	NULL
the	NULL
5	NULL
arm	NULL
of	NULL
ST1	NULL
(	NULL
ST1I-U	NULL
,	NULL
5-GAGGATCCAGTCAGCATG-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14	NULL
)	NULL
for	NULL
15	NULL
to	NULL
30	NULL
cycles	NULL
with	NULL
annealing	NULL
at	NULL
52°C	NULL
.	NULL

The	NULL
amplification	NULL
product	NULL
of	NULL
the	NULL
selected	NULL
probe	NULL
was	NULL
end	NULL
labelled	NULL
,	NULL
and	NULL
approximately	NULL
1	NULL
%	NULL
was	NULL
used	NULL
for	NULL
a	NULL
subsequent	NULL
round	NULL
of	NULL
selection	NULL
.	NULL

After	NULL
five	NULL
rounds	NULL
of	NULL
SAAB	NULL
,	NULL
the	NULL
amplified	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
Bg/lI	NULL
to	NULL
cleave	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
STI	NULL
arms	NULL
and	NULL
cloned	NULL
into	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
of	NULL
independent	NULL
clones	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
commercially	NULL
prepared	NULL
reagents	NULL
(	NULL
Sequenase	NULL
;	NULL
U.S.	NULL
Bio-chemicals	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
)	NULL
and	NULL
visually	NULL
aligned	NULL
.	NULL

Only	NULL
sequences	NULL
derived	NULL
entirely	NULL
from	NULL
the	NULL
internal	NULL
degenerate	NULL
positions	NULL
were	NULL
used	NULL
to	NULL
determine	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
.	NULL

Consensus	NULL
binding	NULL
sites	NULL
for	NULL
various	NULL
EZA-HLF	NULL
proteins	NULL
were	NULL
determined	NULL
in	NULL
an	NULL
identical	NULL
manner	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
six	NULL
,	NULL
rather	NULL
than	NULL
five	NULL
,	NULL
rounds	NULL
of	NULL
SAAB	NULL
were	NULL
employed	NULL
.	NULL

Plasmid	NULL
constructions	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
expression	NULL
plasmids	NULL
pHLF	NULL
,	NULL
pHLF	NULL
``	NULL
,	NULL
pHLFAN®	NULL
``	NULL
``	NULL
°	NULL
,	NULL
pE2A-HLF	NULL
'	NULL
,	NULL
and	NULL
pE2A-HLF	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
use	NULL
the	NULL
terminology	NULL
EH**	NULL
``	NULL
°	NULL
to	NULL
refer	NULL
to	NULL
the	NULL
e13-Ins-e4	NULL
spliced	NULL
protein	NULL
isolated	NULL
from	NULL
the	NULL
HAL-O01	NULL
cell	NULL
line	NULL
which	NULL
contains	NULL
an	NULL
1-526-to-F-526	NULL
somatic	NULL
mutation	NULL
and	NULL
EH*°	NULL
to	NULL
refer	NULL
to	NULL
a	NULL
protein	NULL
in	NULL
which	NULL
this	NULL
position	NULL
has	NULL
been	NULL
reverted	NULL
to	NULL
the	NULL
wild-type	NULL
isoleucine	NULL
residue	NULL
.	NULL

Various	NULL
expression	NULL
plasmids	NULL
were	NULL
modified	NULL
by	NULL
standard	NULL
PCR	NULL
and	NULL
cloning	NULL
procedures	NULL
to	NULL
create	NULL
additional	NULL
constructs	NULL
for	NULL
in	NULL
vitro	NULL
expression	NULL
of	NULL
modified	NULL
wild-type	NULL
or	NULL
fusion	NULL
proteins	NULL
.	NULL

EHU	NULL
(	NULL
a	NULL
plasmid	NULL
that	NULL
expresses	NULL
an	NULL
e13-Ins-e4	NULL
spliced	NULL
fusion	NULL
protein	NULL
which	NULL
contains	NULL
an	NULL
insertion	NULL
different	NULL
from	NULL
that	NULL
in	NULL
the	NULL
HAL-01	NULL
chimera	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
amplifying	NULL
the	NULL
3	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
fusion	NULL
cDNA	NULL
from	NULL
the	NULL
UOC-B1	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-ALL	NULL
cell	NULL
line	NULL
(	NULL
16	NULL
)	NULL
with	NULL
an	NULL
oligomer	NULL
homologous	NULL
to	NULL
sequences	NULL
in	NULL
£24	NULL
exon	NULL
11	NULL
(	NULL
JN3	NULL
,	NULL
5-CGTCCAGC	NULL
CCTTCTACCC-3	NULL
'	NULL
)	NULL
and	NULL
an	NULL
oligomer	NULL
complementary	NULL
to	NULL
HLF	NULL
exon	NULL
4	NULL
sequences	NULL
3	NULL
'	NULL
of	NULL
the	NULL
stop	NULL
codon	NULL
which	NULL
contained	NULL
an	NULL
artificial	NULL
EcoRI	NULL
site	NULL
(	NULL
HLF	NULL
3'Eco	NULL
,	NULL
5-GCGAATTCAGCCAG	NULL
CCTGCAAAAATGCC-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
digested	NULL
with	NULL
Xhol	NULL
(	NULL
a	NULL
natural	NULL
Xhol	NULL
site	NULL
is	NULL
present	NULL
in	NULL
£24	NULL
exon	NULL
11	NULL
)	NULL
and	NULL
EcoRI	NULL
and	NULL
used	NULL
to	NULL
replace	NULL
the	NULL
corresponding	NULL
Xhol-EcoRI	NULL
fragment	NULL
of	NULL
pEH	NULL
'	NULL
``	NULL
.	NULL

An	NULL
identical	NULL
strategy	NULL
was	NULL
employed	NULL
to	NULL
5988	NULL
HUNGER	NULL
ET	NULL
AL	NULL
.	NULL

construct	NULL
the	NULL
expression	NULL
plasmid	NULL
pEH**	NULL
``	NULL
*	NULL
derived	NULL
from	NULL
a	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-ALL	NULL
with	NULL
an	NULL
e12-e4	NULL
spliced	NULL
mRNA	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Two	NULL
additional	NULL
truncation	NULL
mutants	NULL
of	NULL
HLF	NULL
were	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
:	NULL
HLF	NULL
``	NULL
,	NULL
which	NULL
contains	NULL
only	NULL
the	NULL
portion	NULL
of	NULL
HLF	NULL
(	NULL
residues	NULL
225	NULL
to	NULL
295	NULL
,	NULL
encoded	NULL
by	NULL
exon	NULL
4	NULL
)	NULL
present	NULL
in	NULL
the	NULL
EZ2A-HLF	NULL
fusion	NULL
protein	NULL
preceded	NULL
by	NULL
a	NULL
methionine	NULL
residue	NULL
,	NULL
and	NULL
HLF®	NULL
'	NULL
``	NULL
``	NULL
°	NULL
(	NULL
residues	NULL
210	NULL
to	NULL
295	NULL
)	NULL
,	NULL
which	NULL
includes	NULL
15	NULL
additional	NULL
amino	NULL
acids	NULL
which	NULL
compose	NULL
the	NULL
so-called	NULL
basic	NULL
region	NULL
extension	NULL
(	NULL
BRE	NULL
)	NULL
.	NULL

These	NULL
were	NULL
constructed	NULL
by	NULL
PCR	NULL
with	NULL
primer	NULL
HLF	NULL
3'Eco	NULL
and	NULL
specific	NULL
upstream	NULL
primers	NULL
which	NULL
contained	NULL
artificial	NULL
BamHI	NULL
sites	NULL
for	NULL
cloning	NULL
purposes	NULL
(	NULL
HE4	NULL
Met-Bam	NULL
,	NULL
5-GCGGATCC	NULL
GCGATGGATGACAAGTACTGGGCAAGG-3	NULL
'	NULL
,	NULL
and	NULL
HBE	NULL
Met-Bam	NULL
,	NULL
GCAAA-3	NULL
'	NULL
)	NULL
.	NULL

Amplification	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
and	NULL
ligated	NULL
into	NULL
the	NULL
pSP64	NULL
e	NULL
1gression	NULL
plasmid	NULL
.	NULL

The	NULL
artificial	NULL
fusion	NULL
protein	NULL
construct	NULL
EH	NULL
``	NULL
*	NULL
``	NULL
contained	NULL
HLF	NULL
residues	NULL
comprising	NULL
the	NULL
PAR	NULL
and	NULL
BRE	NULL
in	NULL
addition	NULL
to	NULL
HLF	NULL
exon	NULL
4-encoded	NULL
sequences	NULL
(	NULL
amino	NULL
acids	NULL
158	NULL
to	NULL
295	NULL
)	NULL
,	NULL
essentially	NULL
the	NULL
same	NULL
portion	NULL
of	NULL
HLF	NULL
found	NULL
in	NULL
HLF	NULL
``	NULL
.	NULL

Plasmid	NULL
pEH	NULL
'	NULL
``	NULL
**°	NULL
was	NULL
amplified	NULL
with	NULL
JN3	NULL
and	NULL
a	NULL
downstream	NULL
oligomer	NULL
complementary	NULL
to	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
insertion	NULL
with	NULL
a	NULL
3	NULL
'	NULL
BamHI	NULL
overhang	NULL
(	NULL
INSENDBAM	NULL
,	NULL
5-CGCGGATCCCACCAGAAA	NULL
TCTCAGGCG-3	NULL
'	NULL
)	NULL
,	NULL
cut	NULL
with	NULL
Xhol	NULL
and	NULL
BamHI	NULL
and	NULL
ligated	NULL
into	NULL
the	NULL
Xhol-	NULL
and	NULL
EcoRI-cut	NULL
pEH-I	NULL
vector	NULL
along	NULL
with	NULL
a	NULL
portion	NULL
of	NULL
wild-type	NULL
pHLF	NULL
'	NULL
amplified	NULL
with	NULL
HLF	NULL
3'Eco	NULL
and	NULL
an	NULL
upstream	NULL
oligomer	NULL
with	NULL
a	NULL
5	NULL
BamHI	NULL
overhang	NULL
(	NULL
HLFPARBAM	NULL
,	NULL
5-GCG	NULL
GATCCCGCAATACACCAAGTCCC-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
construct	NULL
assembled	NULL
in	NULL
this	NULL
manner	NULL
includes	NULL
E2A	NULL
residues	NULL
1	NULL
to	NULL
477	NULL
,	NULL
the	NULL
HAL-01-derived	NULL
insertion	NULL
,	NULL
two	NULL
residues	NULL
inserted	NULL
by	NULL
the	NULL
cloning	NULL
process	NULL
(	NULL
glycine	NULL
and	NULL
serine	NULL
)	NULL
,	NULL
and	NULL
HLF	NULL
residues	NULL
158	NULL
to	NULL
295	NULL
.	NULL

EH®*	NULL
``	NULL
*	NULL
``	NULL
,	NULL
which	NULL
contains	NULL
residues	NULL
1	NULL
to	NULL
524	NULL
of	NULL
E2A-HLF	NULL
with	NULL
an	NULL
artificial	NULL
stop	NULL
codon	NULL
immediately	NULL
preceding	NULL
the	NULL
HLF	NULL
leucine	NULL
zipper	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
replacing	NULL
the	NULL
Xhol-EcoRI	NULL
fragment	NULL
of	NULL
pEH	NULL
``	NULL
°	NULL
with	NULL
a	NULL
fragment	NULL
generated	NULL
by	NULL
amplifying	NULL
with	NULL
oligomers	NULL
JN3	NULL
and	NULL
HDZ	NULL
(	NULL
5¢-CCGGAATTCGAACTA	NULL
GTTCTCTTTCAGCCTCC-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
portions	NULL
of	NULL
all	NULL
constructs	NULL
were	NULL
sequenced	NULL
to	NULL
ensure	NULL
that	NULL
no	NULL
PCR-induced	NULL
mutations	NULL
had	NULL
occurred	NULL
.	NULL

Transient	NULL
transfections	NULL
and	NULL
transcriptional	NULL
activation	NULL
assays	NULL
.	NULL

For	NULL
transfection	NULL
experiments	NULL
the	NULL
coding	NULL
portions	NULL
of	NULL
various	NULL
in	NULL
vitro	NULL
expression	NULL
plasmids	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
mammalian	NULL
expression	NULL
vector	NULL
pCMV1	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
pET3aTEF	NULL
(	NULL
11	NULL
)	NULL
was	NULL
used	NULL
to	NULL
express	NULL
rat	NULL
TEF	NULL
in	NULL
dominant	NULL
negative	NULL
experiments	NULL
.	NULL

The	NULL
pCMV1	NULL
vector	NULL
without	NULL
transactivator	NULL
insert	NULL
served	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Reporter	NULL
constructs	NULL
were	NULL
assembled	NULL
by	NULL
digesting	NULL
double-stranded	NULL
oligonucleotide	NULL
binding	NULL
sites	NULL
at	NULL
BamHI	NULL
and	NULL
Bg/l	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
invariant	NULL
portions	NULL
and	NULL
concatamerizing	NULL
and	NULL
cloning	NULL
them	NULL
into	NULL
the	NULL
pBLCAT2	NULL
(	NULL
23	NULL
)	NULL
vector	NULL
adjacent	NULL
to	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
promoter	NULL
which	NULL
drives	NULL
expression	NULL
of	NULL
a	NULL
chloramphenicol	NULL
acetyitransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
.	NULL

A	NULL
CAT	NULL
reporter	NULL
driven	NULL
by	NULL
the	NULL
liver	NULL
,	NULL
bone	NULL
,	NULL
and	NULL
kidney	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
AP	NULL
)	NULL
promoter	NULL
with	NULL
eight	NULL
VBP	NULL
VTG	NULL
II	NULL
sites	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
John	NULL
Birch	NULL
;	NULL
for	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
bank	NULL
of	NULL
VBP	NULL
sites	NULL
was	NULL
excised	NULL
and	NULL
replaced	NULL
by	NULL
HLF	NULL
consensus	NULL
sites	NULL
.	NULL

Nomenclature	NULL
used	NULL
indicates	NULL
the	NULL
type	NULL
and	NULL
number	NULL
of	NULL
copies	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
and	NULL
promoter	NULL
;	NULL
for	NULL
example	NULL
,	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
.	NULL

Transient	NULL
transfections	NULL
in	NULL
monkey	NULL
kidney-derived	NULL
CV-1	NULL
cells	NULL
were	NULL
performed	NULL
by	NULL
calcium	NULL
phosphate-mediated	NULL
transfection	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Human	NULL
B-precursor	NULL
ALL	NULL
cell	NULL
lines	NULL
REH	NULL
and	NULL
697	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
DEAE-dextran	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
DNA	NULL
transfected	NULL
within	NULL
each	NULL
experiment	NULL
was	NULL
kept	NULL
constant	NULL
with	NULL
the	NULL
use	NULL
of	NULL
carrier	NULL
plasmid	NULL
DNA	NULL
.	NULL

In	NULL
each	NULL
experiment	NULL
a	NULL
control	NULL
plasmid	NULL
expressing	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
pRSV-lucif-erase	NULL
or	NULL
pSVtk-luciferase	NULL
)	NULL
was	NULL
included	NULL
to	NULL
control	NULL
for	NULL
trans-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

fection	NULL
efficiency	NULL
.	NULL

CAT	NULL
and	NULL
luciferase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
CAT	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
negative	NULL
control	NULL
experiments	NULL
performed	NULL
with	NULL
various	NULL
transac-tivators	NULL
and	NULL
reporter	NULL
constructs	NULL
lacking	NULL
binding	NULL
sites	NULL
.	NULL

For	NULL
each	NULL
experiment	NULL
,	NULL
transfections	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
on	NULL
at	NULL
least	NULL
three	NULL
separate	NULL
occasions	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

RESULTS	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
bind	NULL
preferentially	NULL
to	NULL
an	NULL
identical	NULL
consensus	NULL
DNA	NULL
sequence	NULL
.	NULL

An	NULL
HLF	NULL
consensus	NULL
DNA-binding	NULL
site	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
modified	NULL
SAAB	NULL
procedure	NULL
(	NULL
4	NULL
)	NULL
.	NULL

IVT	NULL
HLF	NULL
was	NULL
incubated	NULL
with	NULL
an	NULL
oligonucleotide	NULL
(	NULL
ST1	NULL
)	NULL
containing	NULL
20	NULL
degenerate	NULL
nucleotides	NULL
flanked	NULL
by	NULL
PCR	NULL
``	NULL
handles	NULL
.	NULL
``	NULL

In	NULL
the	NULL
initial	NULL
round	NULL
of	NULL
EMSA	NULL
,	NULL
using	NULL
the	NULL
fully	NULL
degenerate	NULL
ST	NULL
1	NULL
,	NULL
a	NULL
faint	NULL
shifted	NULL
complex	NULL
was	NULL
observed	NULL
with	NULL
HLF	NULL
but	NULL
not	NULL
with	NULL
control	NULL
lysate	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

With	NULL
each	NULL
successive	NULL
round	NULL
of	NULL
selection	NULL
this	NULL
complex	NULL
became	NULL
more	NULL
prominent	NULL
;	NULL
after	NULL
five	NULL
rounds	NULL
,	NULL
an	NULL
intense	NULL
shifted	NULL
complex	NULL
was	NULL
evident	NULL
.	NULL

The	NULL
DNA	NULL
from	NULL
this	NULL
complex	NULL
was	NULL
amplified	NULL
and	NULL
cloned	NULL
,	NULL
and	NULL
the	NULL
nucleotide	NULL
sequences	NULL
of	NULL
individual	NULL
inserts	NULL
were	NULL
determined	NULL
.	NULL

Comparison	NULL
and	NULL
alignment	NULL
of	NULL
18	NULL
individual	NULL
sequences	NULL
showed	NULL
an	NULL
obvious	NULL
consensus	NULL
binding	NULL
site	NULL
:	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
consensus	NULL
outside	NULL
these	NULL
10	NULL
positions	NULL
.	NULL

This	NULL
sequence	NULL
was	NULL
highly	NULL
similar	NULL
to	NULL
binding	NULL
sites	NULL
previously	NULL
identified	NULL
for	NULL
related	NULL
PAR	NULL
and	NULL
C/EBP	NULL
proteins-see	NULL
Table	NULL
1	NULL
(	NULL
7	NULL
,	NULL
11	NULL
,	NULL
17	NULL
,	NULL
27	NULL
,	NULL
34	NULL
,	NULL
36	NULL
)	NULL
.	NULL

There	NULL
was	NULL
a	NULL
minor	NULL
preference	NULL
(	NULL
39	NULL
%	NULL
)	NULL
for	NULL
C	NULL
at	NULL
the	NULL
+2	NULL
position	NULL
such	NULL
that	NULL
6	NULL
of	NULL
36	NULL
half-sites	NULL
matched	NULL
the	NULL
C/EBP	NULL
high-affinity	NULL
site	NULL
(	NULL
ATTGC	NULL
or	NULL
GCAAT	NULL
)	NULL
(	NULL
34	NULL
)	NULL
;	NULL
this	NULL
contrasted	NULL
to	NULL
10	NULL
of	NULL
36	NULL
matches	NULL
for	NULL
the	NULL
HLF	NULL
consensus	NULL
half-sites	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
this	NULL
consensus	NULL
sequence	NULL
represented	NULL
a	NULL
high-affinity	NULL
HLF-binding	NULL
site	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
site	NULL
with	NULL
and	NULL
without	NULL
100-fold	NULL
excess	NULL
unlabelled	NULL
competitor	NULL
DNAs	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
HLF	NULL
complex	NULL
was	NULL
fully	NULL
inhibited	NULL
by	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
HLF	NULL
consensus	NULL
site	NULL
and	NULL
unaffected	NULL
by	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
an	NULL
unrelated	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
PBX1	NULL
protein	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Complete	NULL
or	NULL
near-complete	NULL
competition	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
excess	NULL
,	NULL
unlabelled	NULL
C/EBP	NULL
site	NULL
or	NULL
the	NULL
TEF	NULL
GH	NULL
site	NULL
used	NULL
in	NULL
our	NULL
earlier	NULL
studies	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
albumin	NULL
D	NULL
and	NULL
VTG	NULL
II	NULL
sites	NULL
(	NULL
which	NULL
were	NULL
used	NULL
to	NULL
clone	NULL
DBP	NULL
and	NULL
VBP	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
effective	NULL
,	NULL
but	NULL
less	NULL
efficient	NULL
,	NULL
competitors	NULL
.	NULL

Our	NULL
previous	NULL
observation	NULL
that	NULL
E2A-HLF	NULL
bound	NULL
less	NULL
avidly	NULL
than	NULL
wild-type	NULL
HLF	NULL
to	NULL
the	NULL
TEF	NULL
GH	NULL
site	NULL
(	NULL
15	NULL
)	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
fusion	NULL
protein	NULL
might	NULL
have	NULL
a	NULL
different	NULL
optimal	NULL
recognition	NULL
sequence	NULL
than	NULL
HLF	NULL
.	NULL

To	NULL
address	NULL
this	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
SAAB	NULL
procedure	NULL
with	NULL
three	NULL
different	NULL
E2A-HLF	NULL
chimeric	NULL
proteins-the	NULL
type	NULL
I	NULL
chimera	NULL
(	NULL
EH*	NULL
``	NULL
*°°	NULL
)	NULL
isolated	NULL
from	NULL
the	NULL
HAL-O1	NULL
cell	NULL
line	NULL
,	NULL
a	NULL
variant	NULL
of	NULL
this	NULL
construct	NULL
(	NULL
EH	NULL
``	NULL
``	NULL
°	NULL
)	NULL
in	NULL
which	NULL
the	NULL
zipper	NULL
mutation	NULL
was	NULL
reverted	NULL
to	NULL
the	NULL
wild-type	NULL
sequence	NULL
,	NULL
and	NULL
a	NULL
type	NULL
II	NULL
E2A-HLF	NULL
fusion	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Following	NULL
six	NULL
rounds	NULL
of	NULL
SAAB	NULL
,	NULL
a	NULL
total	NULL
of	NULL
59	NULL
individual	NULL
clones	NULL
selected	NULL
by	NULL
the	NULL
three	NULL
E2A-HLF	NULL
chimeras	NULL
were	NULL
sequenced	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
three	NULL
fusion	NULL
proteins	NULL
bound	NULL
selectively	NULL
to	NULL
the	NULL
same	NULL
5-GTTACGTAAT-3	NULL
'	NULL
consensus	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
as	NULL
had	NULL
HLF	NULL
.	NULL

A	NULL
total	NULL
of	NULL
34	NULL
of	NULL
59	NULL
individual	NULL
clones	NULL
were	NULL
either	NULL
an	NULL
exact	NULL
match	NULL
(	NULL
r	NULL
=	NULL
11	NULL
)	NULL
or	NULL
contained	NULL
only	NULL
one	NULL
mismatch	NULL
(	NULL
#	NULL
=	NULL
23	NULL
)	NULL
from	NULL
the	NULL
10-bp	NULL
consensus	NULL
.	NULL

In	NULL
general	NULL
,	NULL
sequences	NULL
selected	NULL
by	NULL
the	NULL
fusion	NULL
proteins	NULL
displayed	NULL
a	NULL
tighter	NULL
adherence	NULL
to	NULL
the	NULL
consensus	NULL
than	NULL
wild-type	NULL
HLF	NULL
although	NULL
an	NULL
additional	NULL
round	NULL
of	NULL
SAAB	NULL
was	NULL
employed	NULL
for	NULL
the	NULL
fusion	NULL
proteins	NULL
.	NULL

The	NULL
central	NULL
8-bp	NULL
core	NULL
of	NULL
the	NULL
consensus	NULL
site	NULL
(	NULL
-4	NULL
to	NULL
+4	NULL
)	NULL
displays	NULL
dyad	NULL
symmetry	NULL
,	NULL
whereas	NULL
flanking	NULL
nucleotides	NULL
at	NULL
-5	NULL
and	NULL
+5	NULL
are	NULL
noncomplementary	NULL
.	NULL

However	NULL
,	NULL
44	NULL
%	NULL
of	NULL
the	NULL
HLF-selected	NULL
sites	NULL
contained	NULL
complementary	NULL
nucleotides	NULL
at	NULL
these	NULL
positions	NULL
(	NULL
the	NULL
same	NULL
as	NULL
between	NULL
-2	NULL
and	NULL
+2	NULL
[	NULL
Fig	NULL
.	NULL

1	NULL
]	NULL
)	NULL
,	NULL
as	NULL
did	NULL
VoL	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
``	NULL
RANDOM	NULL
RD	NULL
.	NULL

5	NULL
SEL	NULL
%	NULL
competitor	NULL
§	NULL
w	NULL
L	NULL
$	NULL
g	NULL
2	NULL
&	NULL
g	NULL
a	NULL
a	NULL
o	NULL
2	NULL
u	NULL
,	NULL
u	NULL
.	NULL

0	NULL
a	NULL
m	NULL
x	NULL
9	NULL
-	NULL
$	NULL
g-.p	NULL
5	NULL
i_	NULL
5	NULL
.	NULL

£	NULL
$	NULL
t	NULL
%	NULL
C2	NULL
%	NULL
2	NULL
~d	NULL
Ls	NULL
#	NULL
5	NULL
2	NULL
$	NULL
5	NULL
7	NULL
I	NULL
|	NULL
G	NULL
T	NULL
T	NULL
A	NULL
CoG	NULL
T	NULL
A	NULL
A	NULL
T	NULL
Matche	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Selection	NULL
of	NULL
a	NULL
high-affinity	NULL
HLF	NULL
consensus	NULL
binding	NULL
site	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Wild-type	NULL
HLF	NULL
was	NULL
translated	NULL
in	NULL
vitro	NULL
and	NULL
used	NULL
in	NULL
binding	NULL
reactions	NULL
with	NULL
unselected	NULL
random	NULL
ST-1	NULL
oligonucleotide	NULL
or	NULL
oligonucleotides	NULL
resulting	NULL
from	NULL
five	NULL
rounds	NULL
of	NULL
SAAB	NULL
.	NULL

NEG	NULL
IVT	NULL
,	NULL
translation	NULL
reaction	NULL
programmed	NULL
with	NULL
vector	NULL
alone	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Alignment	NULL
of	NULL
internal	NULL
sequences	NULL
of	NULL
18	NULL
selected	NULL
clones	NULL
.	NULL

The	NULL
nucleotides	NULL
used	NULL
to	NULL
derive	NULL
the	NULL
consensus	NULL
site	NULL
are	NULL
offset	NULL
in	NULL
the	NULL
center	NULL
.	NULL

Positions	NULL
which	NULL
match	NULL
the	NULL
consensus	NULL
are	NULL
in	NULL
uppercase	NULL
type	NULL
,	NULL
and	NULL
those	NULL
which	NULL
differ	NULL
are	NULL
in	NULL
lowercase	NULL
type	NULL
.	NULL

For	NULL
each	NULL
clone	NULL
the	NULL
number	NULL
of	NULL
positions	NULL
that	NULL
do	NULL
not	NULL
match	NULL
the	NULL
consensus	NULL
is	NULL
given	NULL
at	NULL
the	NULL
right	NULL
.	NULL

At	NULL
the	NULL
bottom	NULL
the	NULL
percentage	NULL
of	NULL
matches	NULL
with	NULL
the	NULL
consensus	NULL
at	NULL
each	NULL
position	NULL
is	NULL
listed	NULL
.	NULL

Complementarity	NULL
(	NULL
Compl	NULL
.	NULL
)	NULL

refers	NULL
to	NULL
the	NULL
percentage	NULL
of	NULL
symmetric	NULL
positions	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
ie	NULL
.	NULL

,	NULL
-1	NULL
and	NULL
+1	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

which	NULL
are	NULL
complementary	NULL
to	NULL
one	NULL
another	NULL
in	NULL
individual	NULL
clones	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
radiolabelled	NULL
double-stranded	NULL
HLF	NULL
consensus	NULL
binding	NULL
site	NULL
oligonucleotide	NULL
with	NULL
IVT	NULL
HLF	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
indicated	NULL
unlabelled	NULL
competitor	NULL
oligonucle-otides	NULL
.	NULL

51	NULL
%	NULL
of	NULL
the	NULL
E2A-HLF-selected	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
no	NULL
strong	NULL
selection	NULL
against	NULL
complementarity	NULL
in	NULL
individual	NULL
clones	NULL
.	NULL

Another	NULL
obvious	NULL
feature	NULL
of	NULL
the	NULL
consensus	NULL
is	NULL
the	NULL
pair	NULL
of	NULL
Ts	NULL
at	NULL
-4	NULL
and	NULL
-3	NULL
flanked	NULL
by	NULL
purines	NULL
and	NULL
the	NULL
complementary	NULL
As	NULL
at	NULL
+3	NULL
and	NULL
+4	NULL
flanked	NULL
by	NULL
pyrimidines	NULL
,	NULL
suggesting	NULL
a	NULL
strong	NULL
bias	NULL
against	NULL
three	NULL
or	NULL
more	NULL
consecutive	NULL
purine	NULL
or	NULL
pyrimidine	NULL
nucleotides	NULL
in	NULL
each	NULL
half-site	NULL
.	NULL

Whereas	NULL
site	NULL
selection	NULL
for	NULL
HLF	NULL
did	NULL
not	NULL
reveal	NULL
any	NULL
consensus	NULL
outside	NULL
the	NULL
10-bp	NULL
core	NULL
,	NULL
the	NULL
fusion	NULL
proteins	NULL
displayed	NULL
a	NULL
trend	NULL
toward	NULL
a	NULL
C	NULL
in	NULL
the	NULL
+6	NULL
position	NULL
and	NULL
a	NULL
strong	NULL
selection	NULL
against	NULL
an	NULL
A	NULL
at	NULL
-~7	NULL
.	NULL

The	NULL
DNA-binding	NULL
properties	NULL
of	NULL
E2A-HLF	NULL
show	NULL
site-specific	NULL
TRANSCRIPTIONAL	NULL
REGULATORY	NULL
PROPERTIES	NULL
OF	NULL
E2A-HLF	NULL
5989	NULL
differences	NULL
with	NULL
HLF	NULL
.	NULL

Potential	NULL
differences	NULL
in	NULL
DNA	NULL
binding	NULL
by	NULL
wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
were	NULL
investigated	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
zipper	NULL
mutation	NULL
in	NULL
one	NULL
of	NULL
the	NULL
E2A-HLF	NULL
proteins	NULL
was	NULL
assessed	NULL
in	NULL
constructs	NULL
with	NULL
or	NULL
without	NULL
this	NULL
change	NULL
(	NULL
EH*°	NULL
``	NULL
°	NULL
versus	NULL
EH	NULL
``	NULL
``	NULL
``	NULL
°	NULL
)	NULL
and	NULL
compared	NULL
with	NULL
analogous	NULL
wild-type	NULL
proteins	NULL
(	NULL
HLF	NULL
``	NULL
``	NULL
``	NULL
``	NULL
versus	NULL
HLF	NULL
)	NULL
.	NULL

Binding	NULL
studies	NULL
employed	NULL
IVT	NULL
proteins	NULL
that	NULL
were	NULL
quantitated	NULL
to	NULL
ensure	NULL
that	NULL
approximately	NULL
equal	NULL
amounts	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
.	NULL

The	NULL
binding	NULL
sites	NULL
were	NULL
placed	NULL
in	NULL
the	NULL
same	NULL
oligonucleotide	NULL
backbone	NULL
to	NULL
assess	NULL
differences	NULL
at	NULL
positions	NULL
which	NULL
varied	NULL
from	NULL
the	NULL
consensus	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

EMSA	NULL
showed	NULL
that	NULL
DNA	NULL
binding	NULL
by	NULL
each	NULL
of	NULL
the	NULL
fusion	NULL
proteins	NULL
to	NULL
the	NULL
HLF	NULL
consensus	NULL
site	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
for	NULL
HLF	NULL
and	NULL
the	NULL
zipper	NULL
mutation	NULL
had	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
effect	NULL
on	NULL
binding	NULL
by	NULL
wild-type	NULL
or	NULL
fusion	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
binding	NULL
of	NULL
E2A-HLF	NULL
fusion	NULL
proteins	NULL
EH	NULL
``	NULL
,	NULL
and	NULL
EH	NULL
``	NULL
*~	NULL
to	NULL
sites	NULL
that	NULL
deviated	NULL
from	NULL
the	NULL
consensus	NULL
varied	NULL
from	NULL
that	NULL
of	NULL
wild-type	NULL
HLF	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
was	NULL
binding	NULL
site	NULL
specific	NULL
.	NULL

For	NULL
example	NULL
,	NULL
HLF	NULL
bound	NULL
well	NULL
to	NULL
the	NULL
C/EBP	NULL
high-affinity	NULL
and	NULL
TEF	NULL
GH	NULL
sites	NULL
but	NULL
significantly	NULL
less	NULL
well	NULL
to	NULL
the	NULL
VBP	NULL
VTG	NULL
II	NULL
and	NULL
DBP	NULL
albumin	NULL
D	NULL
sites	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
their	NULL
relative	NULL
abilities	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
HLF	NULL
consensus	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
chimeras	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
bound	NULL
well	NULL
to	NULL
the	NULL
C/EBP	NULL
site	NULL
but	NULL
less	NULL
well	NULL
to	NULL
the	NULL
TEF	NULL
GH	NULL
site	NULL
,	NULL
and	NULL
no	NULL
consistent	NULL
binding	NULL
was	NULL
detected	NULL
to	NULL
the	NULL
VTG	NULL
II	NULL
and	NULL
albumin	NULL
D	NULL
sites	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

The	NULL
binding	NULL
properties	NULL
of	NULL
the	NULL
three	NULL
chimeras	NULL
were	NULL
identical	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
amino	NULL
acid	NULL
differences	NULL
at	NULL
their	NULL
fusion	NULL
sites	NULL
did	NULL
not	NULL
have	NULL
a	NULL
significant	NULL
effect	NULL
on	NULL
DNA	NULL
binding	NULL
.	NULL

Although	NULL
binding	NULL
of	NULL
HLF	NULL
to	NULL
its	NULL
consensus	NULL
site	NULL
was	NULL
not	NULL
significantly	NULL
altered	NULL
by	NULL
a	NULL
point	NULL
mutation	NULL
(	NULL
I-253	NULL
to	NULL
F-253	NULL
)	NULL
in	NULL
its	NULL
leucine	NULL
zipper	NULL
,	NULL
significant	NULL
effects	NULL
were	NULL
observed	NULL
on	NULL
more	NULL
divergent	NULL
sites	NULL
.	NULL

This	NULL
mutation	NULL
abolished	NULL
binding	NULL
to	NULL
the	NULL
VTGII	NULL
and	NULL
albumin	NULL
D	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
same	NULL
zipper	NULL
mutation	NULL
in	NULL
the	NULL
fusion	NULL
protein	NULL
(	NULL
EH*	NULL
``	NULL
°*	NULL
``	NULL
°	NULL
)	NULL
further	NULL
exacerbated	NULL
its	NULL
decreased	NULL
tolerance	NULL
of	NULL
deviation	NULL
from	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
,	NULL
since	NULL
binding	NULL
to	NULL
the	NULL
less	NULL
divergent	NULL
TEF	NULL
GH	NULL
and	NULL
C/EBP	NULL
sites	NULL
was	NULL
further	NULL
impaired	NULL
compared	NULL
with	NULL
that	NULL
to	NULL
EH	NULL
``	NULL
**°	NULL
.	NULL

It	NULL
is	NULL
notable	NULL
that	NULL
binding	NULL
of	NULL
wild-type	NULL
and	NULL
fusion	NULL
proteins	NULL
to	NULL
the	NULL
albumin	NULL
D	NULL
and	NULL
VTG	NULL
II	NULL
sites	NULL
was	NULL
significantly	NULL
different	NULL
from	NULL
that	NULL
to	NULL
the	NULL
C/EBP	NULL
high-affinity	NULL
site	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
each	NULL
matches	NULL
the	NULL
HLF	NULL
consensus	NULL
in	NULL
7	NULL
of	NULL
10	NULL
positions	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
nucleotide	NULL
composition	NULL
of	NULL
these	NULL
sites	NULL
suggested	NULL
at	NULL
least	NULL
two	NULL
possible	NULL
explanations	NULL
for	NULL
these	NULL
differences	NULL
.	NULL

The	NULL
C/EBP	NULL
site	NULL
is	NULL
fully	NULL
dyad	NULL
symmetric	NULL
,	NULL
while	NULL
the	NULL
VTG	NULL
II	NULL
site	NULL
contains	NULL
one	NULL
(	NULL
-1	NULL
to	NULL
+1	NULL
)	NULL
and	NULL
the	NULL
D	NULL
box	NULL
contains	NULL
two	NULL
(	NULL
-1	NULL
to	NULL
+1	NULL
and	NULL
-2	NULL
to	NULL
+2	NULL
)	NULL
positions	NULL
of	NULL
asymmetry	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
site	NULL
selection	NULL
revealed	NULL
a	NULL
strong	NULL
bias	NULL
against	NULL
three	NULL
or	NULL
more	NULL
consecutive	NULL
purine	NULL
or	NULL
pyrimidine	NULL
nucleotides	NULL
in	NULL
either	NULL
half-site	NULL
,	NULL
a	NULL
feature	NULL
present	NULL
in	NULL
both	NULL
VTG	NULL
II	NULL
and	NULL
albumin	NULL
D	NULL
but	NULL
not	NULL
C/EBP	NULL
sites	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
either	NULL
of	NULL
these	NULL
possibilities	NULL
might	NULL
explain	NULL
the	NULL
observed	NULL
differences	NULL
in	NULL
DNA	NULL
binding	NULL
,	NULL
we	NULL
compared	NULL
binding	NULL
by	NULL
various	NULL
proteins	NULL
to	NULL
sites	NULL
in	NULL
which	NULL
the	NULL
HLF	NULL
consensus	NULL
nucleotides	NULL
were	NULL
changed	NULL
to	NULL
T	NULL
at	NULL
-2	NULL
,	NULL
-1	NULL
,	NULL
or	NULL
both	NULL
positions	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Binding	NULL
to	NULL
the	NULL
HLF	NULL
(	NULL
-1T	NULL
)	NULL
site	NULL
was	NULL
similar	NULL
to	NULL
binding	NULL
to	NULL
the	NULL
consensus	NULL
site	NULL
for	NULL
all	NULL
proteins	NULL
,	NULL
indicating	NULL
that	NULL
asymmetry	NULL
is	NULL
tolerated	NULL
at	NULL
this	NULL
central	NULL
position	NULL
.	NULL

Conversely	NULL
,	NULL
binding	NULL
to	NULL
both	NULL
the	NULL
HLF	NULL
(	NULL
-2T	NULL
)	NULL
site	NULL
which	NULL
contains	NULL
three	NULL
consecutive	NULL
Ts	NULL
and	NULL
the	NULL
HLF	NULL
(	NULL
-1	NULL
,	NULL
-2T	NULL
)	NULL
site	NULL
with	NULL
four	NULL
consecutive	NULL
Ts	NULL
was	NULL
substantially	NULL
impaired	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
observed	NULL
alterations	NULL
in	NULL
binding	NULL
to	NULL
the	NULL
VTG	NULL
II	NULL
and	NULL
D	NULL
box	NULL
sites	NULL
are	NULL
largely	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
three	NULL
or	NULL
more	NULL
consecutive	NULL
pyrimidines	NULL
or	NULL
purines	NULL
in	NULL
a	NULL
half-site	NULL
and	NULL
not	NULL
simply	NULL
to	NULL
loss	NULL
of	NULL
dyad	NULL
symmetry	NULL
.	NULL

Impaired	NULL
binding	NULL
of	NULL
E2A-HLF	NULL
is	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
HLF	NULL
residues	NULL
amino	NULL
terminal	NULL
to	NULL
the	NULL
basic	NULL
region	NULL
.	NULL

The	NULL
observed	NULL
differences	NULL
in	NULL
DNA	NULL
binding	NULL
by	NULL
E2A-HLF	NULL
versus	NULL
HLF	NULL
occurred	NULL
despite	NULL
5990	NULL
HUNGER	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

DNA-binding	NULL
properties	NULL
of	NULL
wild-type	NULL
and	NULL
fusion	NULL
proteins	NULL
Relative	NULL
binding	NULL
``	NULL
Site	NULL
Sequence	NULL
-	NULL
-	NULL
-	NULL
HLF	NULL
HLFI-Zh	NULL
}	NULL
EHISZA	NULL
EHI-Slh	NULL
EHUO	NULL
(	NULL
EH	NULL
Type	NULL
?	NULL

HLFA3-155	NULL
HLFAl-Zn	NULL
'	NULL
)	NULL
HLFAl-ZM	NULL
EHPAR	NULL
HLF	NULL
consensus	NULL
GTTACGTAAT	NULL
|	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
TEF	NULL
GH	NULL
GTTACGcAAg	NULL
-	NULL
+++	NULL
+	NULL
++	NULL
+	NULL
++	NULL
++	NULL
+++	NULL
+++	NULL
++	NULL
+++	NULL
C/EBP	NULL
aTTgCGcAAT	NULL
-	NULL
+++	NULL
++	NULL
+++	NULL
++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
+++	NULL
VBP	NULL
VTG	NULL
II	NULL
tTTAtGTAAa	NULL
|	NULL
+	NULL
0	NULL
+/-	NULL
0	NULL
+/-	NULL
+/-	NULL
+	NULL
+/-	NULL
+/-	NULL
+	NULL
DBP	NULL
albumin	NULL
D	NULL
_	NULL
aTTttGTAAT	NULL
-	NULL
+	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
+	NULL
+/-	NULL
0	NULL
+	NULL
HLF	NULL
(	NULL
-21	NULL
)	NULL
GTTtCGTAAT	NULL
-	NULL
++	NULL
0	NULL
+/-	NULL
0	NULL
+/-	NULL
+/-	NULL
++	NULL
+	NULL
0	NULL
++	NULL
HLF	NULL
(	NULL
-11	NULL
)	NULL
GTTAtGTAAT	NULL
-	NULL
+++	NULL
++	NULL
++	NULL
++	NULL
++	NULL
++	NULL
+++	NULL
+++	NULL
++	NULL
+++	NULL
HLF	NULL
(	NULL
-1	NULL
,	NULL
-2T	NULL
)	NULL
-	NULL
GTTtEGTAAT	NULL
-	NULL
+	NULL
0	NULL
0	NULL
0	NULL
0	NULL
0	NULL
+	NULL
0	NULL
0	NULL
+	NULL
``	NULL
Relative	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
naturally	NULL
occurring	NULL
and	NULL
artificial	NULL
sites	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
each	NULL
site	NULL
is	NULL
listed	NULL
in	NULL
a	NULL
5-to-3	NULL
'	NULL
direction	NULL
for	NULL
the	NULL
strand	NULL
which	NULL
most	NULL
closcly	NULL
matches	NULL
the	NULL
HLF	NULL
consensus	NULL
.	NULL

Positions	NULL
which	NULL
match	NULL
the	NULL
consensus	NULL
appear	NULL
in	NULL
uppercase	NULL
type	NULL
,	NULL
and	NULL
those	NULL
which	NULL
differ	NULL
are	NULL
shown	NULL
in	NULL
lowercase	NULL
type	NULL
.	NULL

Binding	NULL
is	NULL
scored	NULL
in	NULL
relation	NULL
to	NULL
wild-type	NULL
HLF	NULL
binding	NULL
to	NULL
the	NULL
HLF	NULL
consensus	NULL
site	NULL
:	NULL
+++	NULL
,	NULL
approximately	NULL
equivalent	NULL
;	NULL
++	NULL
,	NULL
clearly	NULL
reduced	NULL
;	NULL
+	NULL
,	NULL
substantially	NULL
reduced	NULL
;	NULL
+/-	NULL
,	NULL
faint	NULL
binding	NULL
is	NULL
occasionally	NULL
detected	NULL
:	NULL
0	NULL
,	NULL
no	NULL
binding	NULL
detected	NULL
in	NULL
at	NULL
least	NULL
three	NULL
duplicate	NULL
experiments	NULL
.	NULL

intact	NULL
bZIP	NULL
domains	NULL
,	NULL
suggesting	NULL
that	NULL
residues	NULL
outside	NULL
of	NULL
the	NULL
basic	NULL
region	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
determining	NULL
binding	NULL
site	NULL
specificity	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
this	NULL
possibility	NULL
,	NULL
DNA	NULL
binding	NULL
to	NULL
different	NULL
sites	NULL
was	NULL
compared	NULL
by	NULL
using	NULL
variously	NULL
truncated	NULL
HLF	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
focused	NULL
on	NULL
two	NULL
regions	NULL
of	NULL
protein	NULL
homology	NULL
that	NULL
distinguish	NULL
the	NULL
PAR	NULL
subfamily	NULL
from	NULL
other	NULL
bZIP	NULL
proteins	NULL
:	NULL
an	NULL
amino-terminal	NULL
extension	NULL
of	NULL
the	NULL
classic	NULL
basic	NULL
region	NULL
(	NULL
the	NULL
BRE	NULL
)	NULL
and	NULL
the	NULL
adjacent	NULL
PAR	NULL
region	NULL
(	NULL
10	NULL
)	NULL
.	NULL

These	NULL
highly	NULL
conserved	NULL
domains	NULL
are	NULL
not	NULL
present	NULL
in	NULL
E2A-HLF	NULL
,	NULL
since	NULL
each	NULL
fusion	NULL
protein	NULL
contains	NULL
only	NULL
HLF	NULL
residues	NULL
encoded	NULL
by	NULL
exon	NULL
4	NULL
,	NULL
including	NULL
the	NULL
bZIP	NULL
and	NULL
6	NULL
of	NULL
21	NULL
amino	NULL
acids	NULL
which	NULL
compose	NULL
the	NULL
BRE	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Binding	NULL
by	NULL
wild-type	NULL
HLF	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
different	NULL
deleted	NULL
forms	NULL
of	NULL
HLF	NULL
,	NULL
including	NULL
HLF®'~	NULL
>	NULL
*	NULL
,	NULL
which	NULL
contains	NULL
only	NULL
the	NULL
residues	NULL
included	NULL
in	NULL
E2A-HLF	NULL
,	NULL
HLF	NULL
``	NULL
containing	NULL
the	NULL
additional	NULL
15	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
BRE	NULL
,	NULL
and	NULL
HLF	NULL
``	NULL
containing	NULL
the	NULL
BRE	NULL
and	NULL
PAR	NULL
domains	NULL
.	NULL

displayed	NULL
DNA-binding	NULL
properties	NULL
analogous	NULL
to	NULL
those	NULL
of	NULL
the	NULL
fusion	NULL
proteins	NULL
in	NULL
that	NULL
it	NULL
bound	NULL
well	NULL
to	NULL
the	NULL
HLF	NULL
consensus	NULL
,	NULL
TEF	NULL
GH	NULL
,	NULL
and	NULL
C/EBP	NULL
sites	NULL
but	NULL
not	NULL
to	NULL
the	NULL
VTG	NULL
II	NULL
and	NULL
albumin	NULL
D	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
HLF®*	NULL
``	NULL
``	NULL
``	NULL
showed	NULL
binding	NULL
to	NULL
this	NULL
same	NULL
panel	NULL
of	NULL
sites	NULL
that	NULL
was	NULL
indistinguishable	NULL
from	NULL
wild-type	NULL
HLF	NULL
.	NULL

HLFA	NULL
``	NULL
*	NULL
``	NULL
``	NULL
°	NULL
showed	NULL
an	NULL
intermediate	NULL
pattern	NULL
of	NULL
binding	NULL
,	NULL
since	NULL
it	NULL
did	NULL
not	NULL
fully	NULL
reconstitute	NULL
wild-type	NULL
binding	NULL
,	NULL
particularly	NULL
with	NULL
the	NULL
less	NULL
preferred	NULL
sites	NULL
.	NULL

These	NULL
data	NULL
confirm	NULL
and	NULL
extend	NULL
earlier	NULL
observations	NULL
(	NULL
10	NULL
)	NULL
that	NULL
residues	NULL
outside	NULL
the	NULL
basic	NULL
region	NULL
are	NULL
important	NULL
for	NULL
binding	NULL
to	NULL
less	NULL
preferred	NULL
sites	NULL
and	NULL
further	NULL
demonstrate	NULL
that	NULL
residues	NULL
within	NULL
the	NULL
PAR	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
those	NULL
within	NULL
the	NULL
BRE	NULL
,	NULL
are	NULL
necessary	NULL
for	NULL
full	NULL
wild-type	NULL
DNA	NULL
binding	NULL
.	NULL

To	NULL
test	NULL
this	NULL
conclusion	NULL
,	NULL
we	NULL
constructed	NULL
an	NULL
E2A-HLF	NULL
protein	NULL
wherein	NULL
the	NULL
entire	NULL
HLF	NULL
BRE	NULL
and	NULL
PAR	NULL
domains	NULL
were	NULL
reinserted	NULL
into	NULL
EH	NULL
'	NULL
``	NULL
*	NULL
``	NULL
°	NULL
adjacent	NULL
to	NULL
the	NULL
bZIP	NULL
domains	NULL
shared	NULL
by	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
EH	NULL
``	NULL
*	NULL
``	NULL
%	NULL
,	NULL
EH	NULL
``	NULL
*	NULL
``	NULL
®	NULL
bound	NULL
well	NULL
to	NULL
the	NULL
VTG	NULL
II	NULL
and	NULL
albumin	NULL
D	NULL
sites	NULL
and	NULL
its	NULL
binding	NULL
site	NULL
preferences	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
wild-type	NULL
HLF	NULL
as	NULL
measured	NULL
under	NULL
our	NULL
experimental	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
observed	NULL
differences	NULL
in	NULL
DNA	NULL
binding	NULL
by	NULL
E2A-HLF	NULL
did	NULL
not	NULL
result	NULL
from	NULL
properties	NULL
conferred	NULL
by	NULL
E2A	NULL
but	NULL
were	NULL
a	NULL
direct	NULL
consequence	NULL
of	NULL
loss	NULL
of	NULL
residues	NULL
amino	NULL
terminal	NULL
to	NULL
the	NULL
classic	NULL
basic	NULL
region	NULL
that	NULL
are	NULL
specifically	NULL
conserved	NULL
in	NULL
the	NULL
PAR	NULL
subfamily	NULL
of	NULL
bZIP	NULL
proteins	NULL
and	NULL
function	NULL
as	NULL
an	NULL
ancillary	NULL
DNA-binding	NULL
domain	NULL
.	NULL

HLF	NULL
and	NULL
E2A-HLF	NULL
are	NULL
transcriptional	NULL
activators	NULL
with	NULL
divergent	NULL
properties	NULL
dictated	NULL
by	NULL
their	NULL
DNA-binding	NULL
prefer-ences	NULL
.	NULL

The	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
of	NULL
wild-type	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
were	NULL
investigated	NULL
by	NULL
cotransfection	NULL
of	NULL
expression	NULL
vectors	NULL
into	NULL
mammalian	NULL
cells	NULL
along	NULL
with	NULL
reporter	NULL
constructs	NULL
containing	NULL
a	NULL
CAT	NULL
gene	NULL
under	NULL
control	NULL
of	NULL
either	NULL
the	NULL
Fusion	NULL
site	NULL
(	NULL
exon	NULL
4	NULL
border	NULL
)	NULL
|	NULL
74	NULL
HLF	NULL
HLEF253	NULL
bZIP	NULL
PAR	NULL
gre	NULL
HLr	NULL
41224	NULL
h	NULL
A1-209	NULL
l	NULL
HLF	NULL
I7	NULL
A3-155	NULL
p	NULL
HLF	NULL
WZ	NULL
EpytyPe	NULL
2	NULL
l	NULL
1G	NULL
,	NULL
EHI526	NULL
*	NULL
EH	NULL
526	NULL
|___	NULL
E2A	NULL
exons	NULL
113	NULL
_	NULL
(	NULL
77	NULL
LOC	NULL
EH	NULL
Insertion	NULL
_	NULL
[	NULL
i-	NULL
_	NULL
haley	NULL
|___	NULL
E2A	NULL
exons	NULL
1-13	NULL
_	NULL
(	NULL
¥	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Schematic	NULL
diagram	NULL
of	NULL
mutant	NULL
and	NULL
wild-type	NULL
HLF	NULL
proteins	NULL
.	NULL

The	NULL
fusion	NULL
and	NULL
wild-type	NULL
protein	NULL
constructions	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
are	NULL
compared	NULL
with	NULL
wild-type	NULL
HLF	NULL
.	NULL

An	NULL
asterisk	NULL
indicates	NULL
the	NULL
first	NULL
heptad	NULL
repeat	NULL
position	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
which	NULL
is	NULL
occupied	NULL
by	NULL
either	NULL
an	NULL
isoleucine	NULL
(	NULL
1	NULL
)	NULL
or	NULL
phenylalanine	NULL
(	NULL
F	NULL
)	NULL
residue	NULL
(	NULL
HLF	NULL
amino	NULL
acid	NULL
253	NULL
,	NULL
E2A-HLF	NULL
amino	NULL
acid	NULL
526	NULL
)	NULL
.	NULL

The	NULL
insertions	NULL
found	NULL
in	NULL
EH*	NULL
``	NULL
**°	NULL
and	NULL
EHY¢	NULL
chimeras	NULL
are	NULL
composed	NULL
of	NULL
different	NULL
amino	NULL
acids	NULL
.	NULL

The	NULL
site	NULL
in	NULL
HLF	NULL
where	NULL
fusion	NULL
to	NULL
E2A	NULL
proteins	NULL
occurs	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Hatched	NULL
box	NULL
,	NULL
bZIP	NULL
of	NULL
HLF	NULL
;	NULL
filled	NULL
box	NULL
,	NULL
extended	NULL
basic	NULL
region	NULL
(	NULL
BRE	NULL
)	NULL
;	NULL
vertically	NULL
lined	NULL
box	NULL
,	NULL
PAR	NULL
.	NULL

VoL	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
TRANSCRIPTIONAL	NULL
REGULATORY	NULL
PROPERTIES	NULL
OF	NULL
E2A-HLF	NULL
5991	NULL
position	NULL
__	NULL
7	NULL
6	NULL
-s	NULL
4	NULL
23	NULL
22	NULL
uf	NULL
f	NULL
_	NULL
2	NULL
3	NULL
4	NULL
s	NULL
6	NULL
7	NULL
~a	NULL
|	NULL
4o	NULL
|	NULL
3s	NULL
|	NULL
ss	NULL
|	NULL
o	NULL
|	NULL
is	NULL
|	NULL
12	NULL
|	NULL
o	NULL
|	NULL
«	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
«	NULL
#	NULL
E2A-HLE	NULL
F	NULL
%	NULL
A	NULL
o	NULL
|	NULL
1s	NULL
|	NULL
12	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
ss	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
o	NULL
|	NULL
ss	NULL
|	NULL
a	NULL
|	NULL
o	NULL
|	NULL
»	NULL
|	NULL
21	NULL
~	NULL
%	NULL
T	NULL
«	NULL
o	NULL
|	NULL
27	NULL
|	NULL
0	NULL
|100	NULL
|	NULL
s2	NULL
|	NULL
o	NULL
|	NULL
e	NULL
|	NULL
o	NULL
|	NULL
7e	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
se	NULL
|	NULL
7	NULL
|	NULL
13	NULL
(	NULL
n=17	NULL
)	NULL
%	NULL
C	NULL
20	NULL
|	NULL
1s	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
a	NULL
|	NULL
o	NULL
|	NULL
aa	NULL
|	NULL
12	NULL
|	NULL
o	NULL
|	NULL
«	NULL
1	NULL
|	NULL
«	NULL
|	NULL
21	NULL
consensus	NULL
G	NULL
-	NULL
T	NULL
OT	NULL
A	NULL
C0	NULL
@	NULL
To	NULL
A0	NULL
A	NULL
To	NULL
oe	NULL
position	NULL
__	NULL
-7	NULL
-6	NULL
-5	NULL
_	NULL
-4	NULL
8	NULL
2	NULL
S4	NULL
1	NULL
_	NULL
2	NULL
3	NULL
4	NULL
5s	NULL
8	NULL
7	NULL
~a	NULL
|	NULL
3s	NULL
|	NULL
«	NULL
«	NULL
|	NULL
zo	NULL
|	NULL
o	NULL
|	NULL
2s	NULL
|	NULL
«	NULL
|	NULL
o	NULL
|	NULL
ss	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
e	NULL
|	NULL
o	NULL
|	NULL
2	NULL
|	NULL
20	NULL
E2A'HLF	NULL
I	NULL
%	NULL
A	NULL
0	NULL
|	NULL
11	NULL
|	NULL
30	NULL
4	NULL
0	NULL
96	NULL
0	NULL
4	NULL
0	NULL
|	NULL
96	NULL
|	NULL
100	NULL
|	NULL
0	NULL
10	NULL
|	NULL
25	NULL
%	NULL
T	NULL
ze	NULL
|	NULL
22	NULL
|	NULL
o	NULL
|	NULL
os	NULL
|	NULL
74	NULL
|	NULL
o	NULL
|	NULL
a	NULL
|	NULL
o	NULL
|	NULL
as	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
ss	NULL
|	NULL
10	NULL
|	NULL
o	NULL
in=23	NULL
)	NULL
%	NULL
C	NULL
se	NULL
|	NULL
22	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
ar	NULL
|	NULL
o	NULL
|	NULL
17	NULL
|	NULL
«	NULL
|	NULL
o	NULL
|	NULL
as	NULL
|	NULL
sz	NULL
|	NULL
as	NULL
consensus	NULL
G	NULL
T	NULL
OT	NULL
A	NULL
C0	NULL
G	NULL
T	NULL
A	NULL
A	NULL
Tooke	NULL
position	NULL
__	NULL
7	NULL
_	NULL
-6	NULL
5	NULL
_	NULL
-4	NULL
3	NULL
22	NULL
uf	NULL
1	NULL
_	NULL
2	NULL
3	NULL
4	NULL
s	NULL
_	NULL
6	NULL
7	NULL
sa	NULL
|	NULL
sa	NULL
|	NULL
az	NULL
|	NULL
so	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
is	NULL
|	NULL
o	NULL
|	NULL
ss	NULL
|	NULL
s	NULL
|	NULL
o	NULL
|	NULL
e	NULL
|	NULL
11	NULL
|	NULL
«	NULL
|	NULL
12	NULL
E2A-HLFType	NULL
JU	NULL
aar	NULL
o	NULL
|	NULL
az	NULL
|	NULL
1	NULL
|	NULL
s	NULL
|	NULL
o	NULL
|	NULL
ss	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
o	NULL
|	NULL
m	NULL
|100|	NULL
o	NULL
|	NULL
«	NULL
|	NULL
12	NULL
%	NULL
T	NULL
13	NULL
|	NULL
13	NULL
|	NULL
o	NULL
|	NULL
as	NULL
|	NULL
ssa	NULL
|	NULL
o	NULL
|	NULL
11	NULL
|	NULL
o	NULL
|	NULL
sa	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
ss	NULL
|	NULL
12	NULL
|	NULL
19	NULL
(	NULL
n=19	NULL
)	NULL
%	NULL
C	NULL
sa	NULL
|	NULL
13	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
o	NULL
|	NULL
ss	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
21	NULL
|	NULL
o	NULL
|	NULL
21	NULL
|	NULL
«	NULL
o	NULL
|	NULL
se	NULL
consensus	NULL
a	NULL
fT	NULL
OT	NULL
A	NULL
C0	NULL
@	NULL
T	NULL
A	NULL
A	NULL
To	NULL
oe	NULL
position	NULL
__	NULL
-7	NULL
-6	NULL
.5	NULL
_	NULL
4	NULL
28	NULL
22	NULL
4	NULL
1	NULL
_	NULL
2	NULL
3	NULL
4	NULL
s	NULL
6	NULL
7	NULL
sa	NULL
|	NULL
2	NULL
»	NULL
|	NULL
3a	NULL
|	NULL
e7	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
ir	NULL
|	NULL
s	NULL
|	NULL
s1	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
19	NULL
|	NULL
19	NULL
%	NULL
A	NULL
24	NULL
|	NULL
11	NULL
|	NULL
2s	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
7a	NULL
|	NULL
o	NULL
|	NULL
»	NULL
»	NULL
|	NULL
s	NULL
|	NULL
st	NULL
|	NULL
«	NULL
|	NULL
1	NULL
|	NULL
»	NULL
|	NULL
19	NULL
HLF	NULL
%	NULL
T	NULL
1a	NULL
|	NULL
33	NULL
|	NULL
o	NULL
|100	NULL
|	NULL
ae	NULL
|	NULL
o	NULL
|	NULL
17	NULL
|	NULL
o	NULL
|	NULL
se	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
ez	NULL
|	NULL
as	NULL
|	NULL
as	NULL
(	NULL
n=18	NULL
)	NULL
%	NULL
C	NULL
as	NULL
|	NULL
ir	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
s	NULL
|	NULL
o	NULL
|	NULL
o	NULL
|	NULL
»	NULL
|	NULL
2	NULL
|	NULL
o	NULL
|	NULL
17	NULL
|	NULL
an	NULL
|	NULL
as	NULL
consensus	NULL
6	NULL
0	NULL
T	NULL
Ot	NULL
A	NULL
C0	NULL
@	NULL
0	NULL
To	NULL
A-	NULL
aAa	NULL
t	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
bind	NULL
preferentially	NULL
to	NULL
the	NULL
same	NULL
consensus	NULL
site	NULL
.	NULL

The	NULL
results	NULL
of	NULL
binding	NULL
site	NULL
selection	NULL
with	NULL
three	NULL
different	NULL
E2A-HLF	NULL
chimeras	NULL
are	NULL
compared	NULL
with	NULL
selection	NULL
with	NULL
HLF	NULL
.	NULL

The	NULL
number	NULL
(	NULL
#	NULL
)	NULL
of	NULL
individual	NULL
sequences	NULL
on	NULL
which	NULL
the	NULL
consensus	NULL
is	NULL
based	NULL
appears	NULL
below	NULL
each	NULL
protein	NULL
.	NULL

The	NULL
percent	NULL
frequency	NULL
of	NULL
each	NULL
nucleotide	NULL
at	NULL
positions	NULL
-7	NULL
to	NULL
+7	NULL
is	NULL
presented	NULL
in	NULL
tabular	NULL
form	NULL
,	NULL
and	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
is	NULL
listed	NULL
below	NULL
.	NULL

herpes	NULL
simplex	NULL
virus	NULL
(	NULL
HSV	NULL
)	NULL
TK	NULL
or	NULL
liver	NULL
,	NULL
bone	NULL
,	NULL
and	NULL
kidney	NULL
alkaline	NULL
phosphatase	NULL
promoters	NULL
linked	NULL
to	NULL
concatamerized	NULL
binding	NULL
sites	NULL
.	NULL

In	NULL
CV-1	NULL
cells	NULL
,	NULL
wild-type	NULL
HLF	NULL
strongly	NULL
activated	NULL
reporter	NULL
gene	NULL
transcription	NULL
through	NULL
HLF	NULL
consensus	NULL
binding	NULL
sites	NULL
and	NULL
was	NULL
a	NULL
less	NULL
potent	NULL
activator	NULL
of	NULL
reporters	NULL
containing	NULL
VTG	NULL
II	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

HLF®3	NULL
``	NULL
``	NULL
°	NULL
did	NULL
not	NULL
activate	NULL
transcription	NULL
significantly	NULL
above	NULL
background	NULL
levels	NULL
,	NULL
indicating	NULL
that	NULL
portions	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
these	NULL
reporters	NULL
were	NULL
located	NULL
in	NULL
the	NULL
amino-terminal	NULL
half	NULL
of	NULL
wild-type	NULL
HLF	NULL
.	NULL

Basal	NULL
activity	NULL
was	NULL
minimal	NULL
on	NULL
the	NULL
(	NULL
VBP	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
activator	NULL
,	NULL
whereas	NULL
more	NULL
abundant	NULL
basal	NULL
activity	NULL
was	NULL
consistently	NULL
observed	NULL
for	NULL
the	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
,	NULL
perhaps	NULL
reflecting	NULL
the	NULL
presence	NULL
of	NULL
endogenous	NULL
HLF	NULL
,	NULL
or	NULL
related	NULL
proteins	NULL
,	NULL
in	NULL
monkey	NULL
kidney	NULL
cells	NULL
.	NULL

E2A-HLF	NULL
chimeric	NULL
proteins	NULL
strongly	NULL
activated	NULL
transcription	NULL
of	NULL
the	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
in	NULL
CV-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Similar	NULL
levels	NULL
of	NULL
activation	NULL
,	NULL
ranging	NULL
from	NULL
100	NULL
to	NULL
150	NULL
%	NULL
of	NULL
wild-type	NULL
HLF	NULL
activity	NULL
,	NULL
were	NULL
observed	NULL
for	NULL
all	NULL
forms	NULL
of	NULL
the	NULL
chimera	NULL
analyzed	NULL
(	NULL
EH	NULL
``	NULL
*	NULL
``	NULL
°	NULL
,	NULL
EH	NULL
``	NULL
,	NULL
EHV	NULL
,	NULL
and	NULL
EH	NULL
``	NULL
Y	NULL
``	NULL
*	NULL
)	NULL
.	NULL

This	NULL
activation	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
HLF	NULL
bZIP	NULL
domains	NULL
since	NULL
E2A-PBX1	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
same	NULL
portion	NULL
of	NULL
E2	NULL
,	NULL
did	NULL
not	NULL
increase	NULL
CAT	NULL
expression	NULL
above	NULL
background	NULL
levels	NULL
.	NULL

In	NULL
marked	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
seen	NULL
with	NULL
HLF	NULL
,	NULL
when	NULL
the	NULL
fusion	NULL
proteins	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
(	NULL
VBP	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
,	NULL
CAT	NULL
activity	NULL
was	NULL
minimally	NULL
above	NULL
background	NULL
levels	NULL
seen	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
activator	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
with	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
and	NULL
(	NULL
VBP	NULL
)	NULL
,	NULL
reporters	NULL
under	NULL
control	NULL
of	NULL
the	NULL
alkaline	NULL
phosphatase	NULL
rather	NULL
than	NULL
TK	NULL
promoter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
wild-type	NULL
HLF	NULL
and	NULL
wild-type	NULL
E2A-HLF	NULL
were	NULL
capable	NULL
of	NULL
potent	NULL
transcriptional	NULL
activation	NULL
of	NULL
reporters	NULL
containing	NULL
high-affinity	NULL
HLF	NULL
consensus	NULL
binding	NULL
sites	NULL
.	NULL

However	NULL
,	NULL
transcriptional	NULL
activation	NULL
by	NULL
E2A-HLF	NULL
differed	NULL
from	NULL
HLF	NULL
when	NULL
assayed	NULL
on	NULL
more	NULL
divergent	NULL
,	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
such	NULL
as	NULL
that	NULL
found	NULL
in	NULL
the	NULL
VTG	NULL
II	NULL
promoter	NULL
.	NULL

The	NULL
observed	NULL
differences	NULL
in	NULL
transcriptional	NULL
activation	NULL
paralleled	NULL
the	NULL
DNA-binding	NULL
differences	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
and	NULL
likely	NULL
reflected	NULL
the	NULL
loss	NULL
of	NULL
critical	NULL
HLF	NULL
residues	NULL
following	NULL
fusion	NULL
to	NULL
EZA	NULL
.	NULL

To	NULL
test	NULL
this	NULL
,	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
a	NULL
fusion	NULL
construct	NULL
(	NULL
EH	NULL
``	NULL
~	NULL
``	NULL
)	NULL
with	NULL
restored	NULL
DNA-binding	NULL
properties	NULL
was	NULL
tested	NULL
on	NULL
reporter	NULL
genes	NULL
under	NULL
control	NULL
of	NULL
either	NULL
consensus	NULL
or	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
.	NULL

EH**	NULL
``	NULL
strongly	NULL
activated	NULL
transcription	NULL
of	NULL
both	NULL
the	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-	NULL
and	NULL
reporters	NULL
and	NULL
in	NULL
each	NULL
case	NULL
was	NULL
a	NULL
substantially	NULL
more	NULL
potent	NULL
activator	NULL
than	NULL
wild-type	NULL
HLF	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicated	NULL
that	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
may	NULL
be	NULL
markedly	NULL
divergent	NULL
and	NULL
dictated	NULL
by	NULL
specific	NULL
binding	NULL
sequences	NULL
because	NULL
of	NULL
loss	NULL
of	NULL
HLF	NULL
ancillary	NULL
DNA-binding	NULL
regions	NULL
that	NULL
occurs	NULL
following	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
.	NULL

Both	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
are	NULL
transcriptionally	NULL
competent	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
transactivation	NULL
properties	NULL
of	NULL
wild-type	NULL
HLF	NULL
might	NULL
be	NULL
cell	NULL
type	NULL
specific	NULL
and	NULL
to	NULL
investigate	NULL
the	NULL
properties	NULL
of	NULL
E2A-HLF	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
phenotypically	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
which	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
is	NULL
observed	NULL
,	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
in	NULL
the	NULL
B-precursor	NULL
ALL	NULL
cell	NULL
line	NULL
5992	NULL
HUNGER	NULL
ET	NULL
AL	NULL
.	NULL

5	NULL
£	NULL
.	NULL

s	NULL
£	NULL
f	NULL
i	NULL
ors	NULL
(	NULL
uso	NULL
o	NULL
dsc	NULL
z	NULL
5	NULL
55	NULL
G	NULL
$	NULL
:	NULL
f.	NULL
®	NULL
Bs	NULL
,	NULL
|	NULL
|	NULL
I	NULL
HLF	NULL
M	NULL
“	NULL
consensus	NULL
1°	NULL
J	NULL
.cd	NULL
od	NULL
Ed	NULL
.	NULL

i	NULL
k	NULL
C/EBP	NULL
high	NULL
affinity	NULL
aTIqgCGcAAT	NULL
§	NULL
:	NULL
«	NULL
Lal	NULL
``	NULL
l	NULL
raf	NULL
1	NULL
~	NULL
VBP	NULL
VTG	NULL
II	NULL
tTTAtGTAAa	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Comparison	NULL
of	NULL
site-specific	NULL
DNA	NULL
binding	NULL
by	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
proteins	NULL
.	NULL

Mobility	NULL
shift	NULL
analyses	NULL
demonstrate	NULL
DNA-binding	NULL
complexes	NULL
containing	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
proteins	NULL
on	NULL
selected	NULL
sites	NULL
.	NULL

EMSAs	NULL
with	NULL
three	NULL
sites	NULL
are	NULL
aligned	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
for	NULL
results	NULL
of	NULL
binding	NULL
to	NULL
additional	NULL
sites	NULL
)	NULL
;	NULL
the	NULL
protein	NULL
in	NULL
each	NULL
lane	NULL
is	NULL
denoted	NULL
at	NULL
the	NULL
top	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
site	NULL
and	NULL
sequence	NULL
appear	NULL
at	NULL
the	NULL
right	NULL
.	NULL

Positions	NULL
which	NULL
match	NULL
the	NULL
consensus	NULL
are	NULL
shown	NULL
in	NULL
uppercase	NULL
type	NULL
and	NULL
those	NULL
which	NULL
differ	NULL
are	NULL
in	NULL
lowercase	NULL
type	NULL
.	NULL

The	NULL
exposure	NULL
of	NULL
autoradiographs	NULL
differs	NULL
for	NULL
each	NULL
binding	NULL
site	NULL
;	NULL
relative	NULL
binding	NULL
is	NULL
indicated	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

NEG	NULL
IVT	NULL
,	NULL
translate	NULL
programmed	NULL
with	NULL
vector	NULL
alone	NULL
.	NULL

REH	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Wild-type	NULL
HLF	NULL
activated	NULL
CAT	NULL
expression	NULL
in	NULL
REH	NULL
cells	NULL
approximately	NULL
fivefold	NULL
over	NULL
background	NULL
levels	NULL
,	NULL
analogous	NULL
to	NULL
results	NULL
seen	NULL
with	NULL
CV-1	NULL
cells	NULL
.	NULL

Significant	NULL
basal	NULL
activation	NULL
of	NULL
the	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
activator	NULL
.	NULL

This	NULL
background	NULL
activation	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
HLF-binding	NULL
sites	NULL
,	NULL
as	NULL
it	NULL
was	NULL
not	NULL
seen	NULL
with	NULL
reporters	NULL
lacking	NULL
binding	NULL
sites	NULL
or	NULL
with	NULL
reporters	NULL
containing	NULL
C/EBP-binding	NULL
sites	NULL
.	NULL

E2A-HLF	NULL
proteins	NULL
were	NULL
also	NULL
strong	NULL
transcriptional	NULL
activators	NULL
of	NULL
the	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
in	NULL
REH	NULL
cells	NULL
.	NULL

The	NULL
isoleucine-containing	NULL
chimeras	NULL
were	NULL
consistently	NULL
more	NULL
potent	NULL
activators	NULL
than	NULL
wild-type	NULL
HLF	NULL
,	NULL
while	NULL
EH	NULL
``	NULL
*	NULL
``	NULL
°	NULL
was	NULL
similar	NULL
in	NULL
potency	NULL
to	NULL
HLF	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
wild-type	NULL
HLF	NULL
is	NULL
not	NULL
restricted	NULL
in	NULL
its	NULL
transactivation	NULL
capability	NULL
to	NULL
cell	NULL
lineages	NULL
in	NULL
which	NULL
its	NULL
mRNA	NULL
is	NULL
normally	NULL
expressed	NULL
(	NULL
liver	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
lung	NULL
)	NULL
and	NULL
that	NULL
the	NULL
mechanism	NULL
for	NULL
oncogenic	NULL
activation	NULL
of	NULL
HLF	NULL
by	NULL
fusion	NULL
with	NULL
E2A	NULL
is	NULL
not	NULL
a	NULL
simple	NULL
consequence	NULL
of	NULL
converting	NULL
a	NULL
nonlymphoid	NULL
activator	NULL
into	NULL
one	NULL
that	NULL
is	NULL
transcriptionally	NULL
competent	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

HLF	NULL
wild-type	NULL
and	NULL
chimeric	NULL
proteins	NULL
transactivate	NULL
C/EBP	NULL
reporter	NULL
constructs	NULL
.	NULL

As	NULL
wild-type	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
bound	NULL
well	NULL
to	NULL
the	NULL
high-affinity	NULL
C/EBP	NULL
site	NULL
in	NULL
EMSA	NULL
,	NULL
we	NULL
also	NULL
investigated	NULL
whether	NULL
these	NULL
proteins	NULL
could	NULL
activate	NULL
a	NULL
reporter	NULL
containing	NULL
concatamerized	NULL
C/EBP	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Both	NULL
wild-type	NULL
and	NULL
fusion	NULL
proteins	NULL
activated	NULL
CAT	NULL
expression	NULL
from	NULL
(	NULL
C/EBP	NULL
)	NULL
,	NULL
-TK-CAT	NULL
.	NULL

Consistently	NULL
less	NULL
basal	NULL
activation	NULL
of	NULL
the	NULL
(	NULL
C/EBP	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
cotransfected	NULL
activator	NULL
was	NULL
seen	NULL
compared	NULL
with	NULL
results	NULL
with	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
,	NULL
thus	NULL
accounting	NULL
for	NULL
a	NULL
higher	NULL
fold	NULL
induction	NULL
of	NULL
the	NULL
(	NULL
C/EBP	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
results	NULL
seen	NULL
with	NULL
the	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
reporter	NULL
,	NULL
EH*	NULL
``	NULL
°	NULL
``	NULL
°	NULL
was	NULL
less	NULL
potent	NULL
than	NULL
wild-type	NULL
HLF	NULL
or	NULL
the	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

65	NULL
E	NULL
3	NULL
;	NULL
e	NULL
a	NULL
yeu	NULL
``	NULL
u	NULL
.	NULL

|_	NULL
4	NULL
&	NULL
&	NULL
40	NULL
4	NULL
L	NULL
2	NULL
'	NULL
£	NULL
f	NULL
&	NULL
G	NULL
u	NULL
I	NULL
|	NULL
I	NULL
|	NULL
I	NULL
ame	NULL
TP	NULL
ind	NULL
HLF	NULL
I	NULL
;	NULL
consensus	NULL
C/EBP	NULL
i	NULL
high	NULL
affinity	NULL
VBP	NULL
VTG	NULL
II	NULL
tTTAtGTAAa	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

DNA-binding	NULL
alterations	NULL
are	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
an	NULL
HLF	NULL
ancillary	NULL
DNA-binding	NULL
domain	NULL
.	NULL

Mobility	NULL
shift	NULL
analyses	NULL
show	NULL
DNA	NULL
binding	NULL
by	NULL
various	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
proteins	NULL
to	NULL
selected	NULL
sites	NULL
.	NULL

The	NULL
protein	NULL
in	NULL
each	NULL
lane	NULL
is	NULL
denoted	NULL
at	NULL
the	NULL
top	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
site	NULL
and	NULL
sequence	NULL
appear	NULL
at	NULL
the	NULL
right	NULL
.	NULL

Positions	NULL
which	NULL
match	NULL
the	NULL
consensus	NULL
are	NULL
in	NULL
uppercase	NULL
type	NULL
,	NULL
and	NULL
those	NULL
which	NULL
differ	NULL
are	NULL
in	NULL
lowercase	NULL
type	NULL
.	NULL

The	NULL
exposure	NULL
of	NULL
autoradiographs	NULL
differs	NULL
for	NULL
each	NULL
binding	NULL
site	NULL
;	NULL
relative	NULL
binding	NULL
is	NULL
indicated	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

NEG	NULL
IVT	NULL
,	NULL
translate	NULL
programmed	NULL
with	NULL
vector	NULL
alone	NULL
.	NULL

other	NULL
fusion	NULL
proteins	NULL
,	NULL
compatible	NULL
with	NULL
differences	NULL
observed	NULL
in	NULL
protein	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

E2A-HLF	NULL
is	NULL
capable	NULL
of	NULL
dominant-negative	NULL
inhibition	NULL
of	NULL
transcription	NULL
mediated	NULL
by	NULL
wild-type	NULL
TEF	NULL
.	NULL

The	NULL
disparate	NULL
transcriptional	NULL
properties	NULL
of	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
observed	NULL
on	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
suggested	NULL
that	NULL
interactions	NULL
between	NULL
E2A-HLF	NULL
and	NULL
wild-type	NULL
PAR	NULL
proteins	NULL
could	NULL
potentially	NULL
occur	NULL
and	NULL
significantly	NULL
alter	NULL
the	NULL
normal	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
latter	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
previous	NULL
studies	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
E2A-HLF	NULL
can	NULL
heterodimerize	NULL
with	NULL
each	NULL
of	NULL
the	NULL
wild-type	NULL
PAR	NULL
proteins	NULL
(	NULL
15	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
such	NULL
heterodimers	NULL
,	NULL
we	NULL
performed	NULL
cotransfections	NULL
with	NULL
TEF	NULL
expression	NULL
constructs	NULL
.	NULL

TEF	NULL
was	NULL
chosen	NULL
for	NULL
these	NULL
experiments	NULL
because	NULL
its	NULL
mRNA	NULL
is	NULL
expressed	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
and	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
A	NULL
I	NULL
I	NULL
I	NULL
I	NULL
T	NULL
I	NULL
Transactivator	NULL
NEG	NULL
HLF	NULL
E2A-HLF	NULL
NEG	NULL
HLF	NULL
E2A-HLF	NULL
Reporter	NULL
HUT	NULL
}	NULL
4	NULL
TK-CAT	NULL
(	NULL
VBP	NULL
$	NULL
TK-CAT	NULL
B	NULL
NEG	NULL
@	NULL
(	NULL
HLFJ4	NULL
~TK-CAT	NULL
(	NULL
VBP	NULL
)	NULL
,	NULL
-TK-CAT	NULL
25	NULL
so	NULL
75	NULL
100	NULL
125	NULL
150	NULL
175	NULL
200	NULL
225	NULL
%	NULL
of	NULL
HLF	NULL
transactivation	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Transactivation	NULL
properties	NULL
of	NULL
wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
on	NULL
optimal	NULL
and	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
in	NULL
CV-1	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Representative	NULL
results	NULL
of	NULL
CAT	NULL
assays	NULL
assessing	NULL
relative	NULL
transcriptional	NULL
properties	NULL
of	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
``	NULL
``	NULL
°	NULL
on	NULL
reporter	NULL
genes	NULL
containing	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
TK	NULL
minimal	NULL
promoter	NULL
linked	NULL
to	NULL
optimal	NULL
(	NULL
HLF	NULL
)	NULL
or	NULL
nonoptimal	NULL
(	NULL
VBP	NULL
)	NULL
binding	NULL
sites	NULL
.	NULL

NEG	NULL
,	NULL
reporter	NULL
cotransfected	NULL
with	NULL
pCMV1	NULL
expression	NULL
vector	NULL
lacking	NULL
transactivator	NULL
insert	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Histogram	NULL
showing	NULL
relative	NULL
transactivation	NULL
properties	NULL
of	NULL
wild-type	NULL
and	NULL
fusion	NULL
HLF	NULL
proteins	NULL
on	NULL
reporter	NULL
constructs	NULL
containing	NULL
optimal	NULL
(	NULL
HLF	NULL
)	NULL
or	NULL
nonoptimal	NULL
(	NULL
VBP	NULL
)	NULL
binding	NULL
sites	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
averages	NULL
of	NULL
duplicate	NULL
determinations	NULL
and	NULL
standard	NULL
deviations	NULL
for	NULL
six	NULL
[	NULL
(	NULL
HLF	NULL
)	NULL
,	NULL
-TK-CAT	NULL
]	NULL
or	NULL
three	NULL
[	NULL
{	NULL
(	NULL
VBP	NULL
)	NULL
&	NULL
;	NULL
-TK-CAT	NULL
]	NULL
independently	NULL
performed	NULL
experiments	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
activation	NULL
observed	NULL
for	NULL
wild-type	NULL
HLF	NULL
.	NULL

NEG	NULL
,	NULL
reporter	NULL
without	NULL
cotransfected	NULL
activator	NULL
construct	NULL
.	NULL

HLF	NULL
``	NULL
denotes	NULL
the	NULL
HLF®	NULL
>	NULL
``	NULL
``	NULL
°	NULL
protein	NULL
.	NULL

its	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
are	NULL
essentially	NULL
identical	NULL
to	NULL
those	NULL
of	NULL
HLF	NULL
when	NULL
assayed	NULL
with	NULL
the	NULL
binding	NULL
sites	NULL
utilized	NULL
in	NULL
this	NULL
report	NULL
(	NULL
12	NULL
)	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
reporters	NULL
containing	NULL
the	NULL
nonoptimal	NULL
VTG	NULL
II	NULL
sites	NULL
were	NULL
used	NULL
since	NULL
they	NULL
enabled	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
EZ2A-HLF	NULL
and	NULL
TEF	NULL
to	NULL
be	NULL
readily	NULL
distinguished	NULL
.	NULL

When	NULL
TEF	NULL
was	NULL
transfected	NULL
with	NULL
the	NULL
(	NULL
VBP	NULL
)	NULL
,	NULL
-AP-CAT	NULL
reporter	NULL
into	NULL
CV-1	NULL
or	NULL
697	NULL
(	NULL
human	NULL
pre-B	NULL
ALL	NULL
)	NULL
cells	NULL
,	NULL
robust	NULL
transactivation	NULL
of	NULL
CAT	NULL
expression	NULL
was	NULL
observed	NULL
.	NULL

However	NULL
,	NULL
cotransfection	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
E2A-HLF	NULL
with	NULL
a	NULL
fixed	NULL
amount	NULL
of	NULL
TEF	NULL
led	NULL
to	NULL
a	NULL
progressive	NULL
decline	NULL
in	NULL
TEF-mediated	NULL
transactivation	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Qualitatively	NULL
similar	NULL
reductions	NULL
were	NULL
observed	NULL
with	NULL
either	NULL
EH	NULL
``	NULL
``	NULL
``	NULL
°	NULL
or	NULL
EH	NULL
``	NULL
chimeras	NULL
in	NULL
both	NULL
CV-1	NULL
and	NULL
697	NULL
cells	NULL
,	NULL
with	NULL
a	NULL
reduction	NULL
to	NULL
levels	NULL
seen	NULL
with	NULL
E2A-HLF	NULL
alone	NULL
when	NULL
5-	NULL
to	NULL
10-fold	NULL
more	NULL
E2A-HLF	NULL
than	NULL
TEF	NULL
expression	NULL
construct	NULL
was	NULL
transfected	NULL
.	NULL

The	NULL
observed	NULL
inhibition	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
the	NULL
E2A	NULL
portion	NULL
of	NULL
the	NULL
chimera	NULL
since	NULL
HLF	NULL
``	NULL
also	NULL
had	NULL
significant	NULL
dominant-negative	NULL
effects	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
non-specific	NULL
squelching	NULL
did	NULL
not	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
dominant-negative	NULL
effects	NULL
,	NULL
identical	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
TRANSCRIPTIONAL	NULL
REGULATORY	NULL
PROPERTIES	NULL
OF	NULL
E2A-HLF	NULL
5993	NULL
Fold	NULL
Induction	NULL
_	NULL
(	NULL
C/EBP	NULL
)	NULL
,	NULL
-TK-CAT	NULL
{	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
30	NULL
35	NULL
40	NULL
45	NULL
50	NULL
r	NULL
1	NULL
1	NULL
h	NULL
1	NULL
1	NULL
L	NULL
L	NULL
i	NULL
i	NULL
h	NULL
EHType	NULL
It	NULL
|	NULL
_	NULL
``	NULL
_|	NULL
EHUOC	NULL
EHISZG	NULL
EH	NULL
F526	NULL
HLF	NULL
NEG	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
1	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
12	NULL
14	NULL
16	NULL
18	NULL
20	NULL
Fold	NULL
Induction	NULL
_	NULL
(	NULL
HLF	NULL
)	NULL
-TK-CAT	NULL
H	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
display	NULL
transcriptional	NULL
activation	NULL
properties	NULL
on	NULL
optimal	NULL
binding	NULL
sites	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
chimeric	NULL
and	NULL
wild-type	NULL
HLF	NULL
proteins	NULL
was	NULL
assessed	NULL
on	NULL
reporter	NULL
genes	NULL
following	NULL
cotransfections	NULL
into	NULL
B-precursor	NULL
ALL	NULL
REH	NULL
cells	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
averages	NULL
of	NULL
duplicate	NULL
determinations	NULL
and	NULL
standard	NULL
deviations	NULL
of	NULL
four	NULL
independently	NULL
performed	NULL
experiments	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
of	NULL
activation	NULL
seen	NULL
with	NULL
pCMV1	NULL
expression	NULL
vector	NULL
lacking	NULL
activator	NULL
insert	NULL
(	NULL
NEG	NULL
)	NULL
.	NULL

Reporter	NULL
constructs	NULL
and	NULL
relative	NULL
scales	NULL
are	NULL
indicated	NULL
above	NULL
and	NULL
below	NULL
the	NULL
bar	NULL
graph	NULL
.	NULL

mutant	NULL
fusion	NULL
protein	NULL
(	NULL
EH**	NULL
'	NULL
``	NULL
[	NULL
Fig	NULL
.	NULL

2	NULL
]	NULL
)	NULL
unable	NULL
to	NULL
dimerize	NULL
with	NULL
TEF	NULL
because	NULL
of	NULL
deletion	NULL
of	NULL
its	NULL
leucine	NULL
zipper	NULL
.	NULL

Western	NULL
blot	NULL
(	NULL
immunoblot	NULL
)	NULL
analgsis	NULL
of	NULL
transfected	NULL
cells	NULL
indicated	NULL
that	NULL
similar	NULL
amounts	NULL
of	NULL
EH*®*	NULL
'	NULL
``	NULL
and	NULL
other	NULL
E2A-HLF	NULL
proteins	NULL
were	NULL
100	NULL
7	NULL
Percent	NULL
maximal	NULL
conversion	NULL
1	NULL
a	NULL
§	NULL
§	NULL
&	NULL
N	NULL
§	NULL
N	NULL
NJ	NULL
NJ	NULL
N	NULL
&	NULL
§o	NULL
&	NULL
§	NULL
§	NULL
§	NULL
&	NULL
&	NULL
FQ	NULL
§	NULL
§	NULL
§	NULL
N	NULL
Nk	NULL
R	NULL
R	NULL
&	NULL
R	NULL
R	NULL
R	NULL
N	NULL
N	NULL
&	NULL
&	NULL
N	NULL
N	NULL
§	NULL
R	NULL
R	NULL
Ki	NULL
N	NULL
&	NULL
N	NULL
R	NULL
N	NULL
&	NULL
R	NULL
R	NULL
&	NULL
N	NULL
&	NULL
R	NULL
R	NULL
N	NULL
N	NULL
N	NULL
&	NULL
§	NULL
bl	NULL
lees	NULL
e	NULL
1:1	NULL
1:2	NULL
1:5	NULL
1:10	NULL
Molar	NULL
ratio	NULL
TEF	NULL
:	NULL
HLF	NULL
constructs	NULL
®	NULL
eHF526	NULL
HLF	NULL
``	NULL
``	NULL
>	NULL
inv	NULL
@	NULL
en§26	NULL
incv1	NULL
@	NULL
eH42P	NULL
incvi	NULL
O	NULL
ew	NULL
inga7	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

E2A-HLF	NULL
displays	NULL
dominant	NULL
negative	NULL
transcriptional	NULL
properties	NULL
on	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
.	NULL

Histogram	NULL
showing	NULL
effects	NULL
on	NULL
TEF-mediated	NULL
transactivation	NULL
of	NULL
(	NULL
VBP	NULL
)	NULL
,	NULL
-AP-CAT	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
molar	NULL
ratios	NULL
of	NULL
various	NULL
chimeric	NULL
and	NULL
mutant	NULL
HLF	NULL
proteins	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
averages	NULL
of	NULL
duplicate	NULL
determinations	NULL
and	NULL
expressed	NULL
as	NULL
the	NULL
percentage	NULL
of	NULL
activation	NULL
observed	NULL
for	NULL
TEF	NULL
alone	NULL
.	NULL

Each	NULL
construct	NULL
was	NULL
analyzed	NULL
in	NULL
at	NULL
least	NULL
two	NULL
different	NULL
experiments	NULL
on	NULL
separate	NULL
occa-sions	NULL
.	NULL

Constructs	NULL
and	NULL
cells	NULL
employed	NULL
for	NULL
each	NULL
experiment	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
M	NULL
,	NULL
EH	NULL
``	NULL
in	NULL
CV-1	NULL
;	NULL
§	NULL
,	NULL
HLF	NULL
``	NULL
in	NULL
CV-1	NULL
;	NULL
&	NULL
,	NULL
EH	NULL
``	NULL
in	NULL
CV-1	NULL
;	NULL
©	NULL
,	NULL
EH	NULL
``	NULL
in	NULL
CV-1	NULL
;	NULL
0	NULL
,	NULL
EH*	NULL
``	NULL
**	NULL
``	NULL
°	NULL
in	NULL
697	NULL
.	NULL

5994	NULL
HUNGER	NULL
ET	NULL
AL	NULL
.	NULL

present	NULL
(	NULL
12	NULL
)	NULL
.	NULL

TEF-mediated	NULL
transcriptional	NULL
activation	NULL
was	NULL
not	NULL
significantly	NULL
affected	NULL
by	NULL
excess	NULL
EH	NULL
``	NULL
.	NULL

DISCUSSION	NULL
The	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
were	NULL
undertaken	NULL
to	NULL
investigate	NULL
the	NULL
transcriptional	NULL
consequences	NULL
of	NULL
E2A-HLF	NULL
fusion	NULL
which	NULL
occurs	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
ALLs	NULL
bearing	NULL
a	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q21-q22	NULL
;	NULL
p13	NULL
)	NULL
translocation	NULL
.	NULL

Structural	NULL
features	NULL
predict	NULL
that	NULL
EZ2A-HLF	NULL
should	NULL
function	NULL
as	NULL
a	NULL
chimeric	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
cognate	NULL
HLF	NULL
sites	NULL
in	NULL
target	NULL
gene	NULL
promoters	NULL
and	NULL
activates	NULL
transcription	NULL
via	NULL
specific	NULL
E2A	NULL
effector	NULL
domains	NULL
.	NULL

Our	NULL
studies	NULL
demonstrate	NULL
experimentally	NULL
that	NULL
E2A-HLF	NULL
does	NULL
indeed	NULL
possess	NULL
such	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
.	NULL

However	NULL
,	NULL
while	NULL
both	NULL
HLF	NULL
and	NULL
EZA-HLF	NULL
bind	NULL
avidly	NULL
to	NULL
,	NULL
and	NULL
activate	NULL
transcription	NULL
via	NULL
,	NULL
the	NULL
consensus	NULL
sequence	NULL
5-GTT	NULL
ACGTAAT-3	NULL
'	NULL
,	NULL
significant	NULL
differences	NULL
in	NULL
both	NULL
DNA-binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
are	NULL
seen	NULL
on	NULL
certain	NULL
closely	NULL
related	NULL
sites	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
physiologic	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
are	NULL
not	NULL
generally	NULL
exact	NULL
matches	NULL
with	NULL
in	NULL
vitro-selected	NULL
binding	NULL
sites	NULL
,	NULL
these	NULL
differences	NULL
may	NULL
have	NULL
significant	NULL
consequences	NULL
with	NULL
respect	NULL
to	NULL
leukemogenic	NULL
target	NULL
genes	NULL
regulated	NULL
by	NULL
the	NULL
chimera	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
studies	NULL
have	NULL
important	NULL
implications	NULL
for	NULL
understanding	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
HLF	NULL
and	NULL
the	NULL
PAR	NULL
subfamily	NULL
of	NULL
bZIP	NULL
proteins	NULL
.	NULL

HLF	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
.	NULL

Our	NULL
studies	NULL
demonstrate	NULL
that	NULL
HLF	NULL
functions	NULL
experimentally	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
reporter	NULL
constructs	NULL
containing	NULL
appropriate	NULL
binding	NULL
sites	NULL
upstream	NULL
of	NULL
minimal	NULL
promoters	NULL
.	NULL

HLF	NULL
was	NULL
transcriptionally	NULL
competent	NULL
in	NULL
both	NULL
CV-1	NULL
monkey	NULL
kidney	NULL
cells	NULL
which	NULL
express	NULL
wild-type	NULL
HLF	NULL
mRNA	NULL
and	NULL
in	NULL
human	NULL
B-precursor	NULL
ALL	NULL
cells	NULL
in	NULL
which	NULL
HLF	NULL
mRNA	NULL
is	NULL
normally	NULL
absent	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
HLF	NULL
can	NULL
activate	NULL
transcription	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
which	NULL
also	NULL
do	NULL
not	NULL
express	NULL
HLF	NULL
mRNA	NULL
(	NULL
12	NULL
)	NULL
.	NULL

This	NULL
property	NULL
clearly	NULL
distinguishes	NULL
HLF	NULL
from	NULL
the	NULL
closely	NULL
related	NULL
PAR	NULL
protein	NULL
DBP	NULL
which	NULL
is	NULL
transcriptionally	NULL
competent	NULL
only	NULL
in	NULL
hepatocytes	NULL
or	NULL
hepatocyte-derived	NULL
cell	NULL
lines	NULL
(	NULL
21	NULL
,	NULL
27	NULL
,	NULL
36	NULL
)	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
HLF	NULL
is	NULL
more	NULL
functionally	NULL
analogous	NULL
to	NULL
TEF/VBP	NULL
;	NULL
in	NULL
fact	NULL
,	NULL
in	NULL
these	NULL
and	NULL
other	NULL
studies	NULL
(	NULL
12	NULL
)	NULL
we	NULL
have	NULL
observed	NULL
no	NULL
differences	NULL
between	NULL
HLF	NULL
and	NULL
TEF	NULL
with	NULL
respect	NULL
to	NULL
either	NULL
binding	NULL
site	NULL
preferences	NULL
or	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
.	NULL

It	NULL
is	NULL
apparent	NULL
from	NULL
the	NULL
DNA-binding	NULL
studies	NULL
presented	NULL
herein	NULL
and	NULL
earlier	NULL
by	NULL
others	NULL
that	NULL
PAR	NULL
proteins	NULL
are	NULL
capable	NULL
of	NULL
substantial	NULL
cross-recognition	NULL
of	NULL
various	NULL
binding	NULL
sites	NULL
(	NULL
11	NULL
,	NULL
15	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
PAR	NULL
proteins	NULL
to	NULL
heterodimerize	NULL
with	NULL
one	NULL
another	NULL
introduces	NULL
an	NULL
additional	NULL
layer	NULL
of	NULL
complexity	NULL
.	NULL

The	NULL
situation	NULL
is	NULL
further	NULL
complicated	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
PAR	NULL
proteins	NULL
to	NULL
sites	NULL
recognized	NULL
by	NULL
C/EBP	NULL
proteins	NULL
and	NULL
vice	NULL
versa	NULL
,	NULL
although	NULL
heterodimerization	NULL
between	NULL
proteins	NULL
in	NULL
the	NULL
different	NULL
classes	NULL
has	NULL
not	NULL
been	NULL
observed	NULL
and	NULL
structural	NULL
constraints	NULL
predict	NULL
that	NULL
it	NULL
should	NULL
not	NULL
occur	NULL
(	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
PAR	NULL
and	NULL
C/EBP	NULL
proteins	NULL
can	NULL
interact	NULL
by	NULL
other	NULL
mechanisms	NULL
,	NULL
as	NULL
DBP	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
synergize	NULL
with	NULL
C/EBP	NULL
in	NULL
postpubertal	NULL
activation	NULL
of	NULL
the	NULL
factor	NULL
IX	NULL
promoter	NULL
that	NULL
occurs	NULL
in	NULL
hemophilia	NULL
B	NULL
Leyden	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
of	NULL
this	NULL
synergy	NULL
is	NULL
undefined	NULL
but	NULL
does	NULL
not	NULL
involve	NULL
direct	NULL
DNA	NULL
binding	NULL
by	NULL
heterodimers	NULL
.	NULL

Thus	NULL
,	NULL
PAR	NULL
proteins	NULL
by	NULL
themselves	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
C/EBP	NULL
proteins	NULL
potentially	NULL
comprise	NULL
a	NULL
complex	NULL
regulatory	NULL
network	NULL
,	NULL
particularly	NULL
in	NULL
the	NULL
liver	NULL
,	NULL
where	NULL
many	NULL
of	NULL
these	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
expressed	NULL
simultaneously	NULL
.	NULL

It	NULL
will	NULL
be	NULL
technically	NULL
challenging	NULL
to	NULL
experimentally	NULL
sort	NULL
out	NULL
the	NULL
relative	NULL
contributions	NULL
of	NULL
individual	NULL
proteins	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
specific	NULL
genes	NULL
;	NULL
however	NULL
,	NULL
such	NULL
combinatorial	NULL
regulatory	NULL
networks	NULL
are	NULL
also	NULL
a	NULL
common	NULL
feature	NULL
of	NULL
other	NULL
transcription	NULL
factor	NULL
families	NULL
.	NULL

Divergence	NULL
in	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
between	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

E2A-HLF	NULL
and	NULL
HLF	NULL
.	NULL

Similar	NULL
to	NULL
HLF	NULL
,	NULL
E2A-HLF	NULL
chimeric	NULL
proteins	NULL
isolated	NULL
from	NULL
different	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-bearing	NULL
leukemias	NULL
strongly	NULL
activated	NULL
transcription	NULL
of	NULL
reporter	NULL
genes	NULL
through	NULL
both	NULL
the	NULL
HLF	NULL
consensus	NULL
binding	NULL
site	NULL
and	NULL
a	NULL
C/EBP	NULL
high-affinity	NULL
site	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
E2A-HLF	NULL
fusion	NULL
proteins	NULL
displayed	NULL
identical	NULL
transcriptional	NULL
potencies	NULL
,	NULL
despite	NULL
the	NULL
fact	NULL
that	NULL
type	NULL
II	NULL
chimeras	NULL
lack	NULL
residues	NULL
encoded	NULL
by	NULL
£24	NULL
exon	NULL
13	NULL
that	NULL
have	NULL
been	NULL
suggested	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
by	NULL
some	NULL
investigators	NULL
(	NULL
2	NULL
)	NULL
,	NULL
although	NULL
not	NULL
by	NULL
others	NULL
(	NULL
30	NULL
)	NULL
,	NULL
in	NULL
one	NULL
of	NULL
the	NULL
two	NULL
identified	NULL
E2A	NULL
activation	NULL
domains	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
exon	NULL
13-encoded	NULL
portion	NULL
of	NULL
E2A	NULL
proteins	NULL
does	NULL
not	NULL
contribute	NULL
significantly	NULL
to	NULL
transcriptional	NULL
activation	NULL
by	NULL
E2A-HLF	NULL
in	NULL
lymphoid	NULL
or	NULL
kidney	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
differed	NULL
in	NULL
two	NULL
potentially	NULL
important	NULL
respects	NULL
.	NULL

E2A-HLF	NULL
was	NULL
clearly	NULL
a	NULL
more	NULL
robust	NULL
activator	NULL
in	NULL
lymphoid	NULL
cells	NULL
phenotypically	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
which	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
is	NULL
observed	NULL
,	NULL
whereas	NULL
their	NULL
potencies	NULL
were	NULL
more	NULL
similar	NULL
in	NULL
CV-1	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
transcriptional	NULL
properties	NULL
of	NULL
E2A-HLF	NULL
diverged	NULL
from	NULL
those	NULL
of	NULL
HLF	NULL
consequent	NULL
to	NULL
alterations	NULL
in	NULL
DNA	NULL
binding	NULL
which	NULL
,	NULL
simplistically	NULL
,	NULL
can	NULL
be	NULL
summarized	NULL
as	NULL
a	NULL
reduced	NULL
tolerance	NULL
of	NULL
E2A-HLF	NULL
for	NULL
certain	NULL
deviations	NULL
from	NULL
the	NULL
consensus	NULL
that	NULL
create	NULL
a	NULL
less	NULL
preferred	NULL
binding	NULL
site	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
E2A-HLF	NULL
chimeras	NULL
with	NULL
wild-type	NULL
zipper	NULL
domains	NULL
displayed	NULL
analogous	NULL
site	NULL
preferences	NULL
and	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
despite	NULL
differences	NULL
in	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
at	NULL
the	NULL
site	NULL
of	NULL
protein	NULL
fusion	NULL
.	NULL

Furthermore	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
,	NULL
as	NULL
occurs	NULL
in	NULL
at	NULL
least	NULL
one	NULL
reported	NULL
E2A-HLF	NULL
chimera	NULL
(	NULL
15	NULL
)	NULL
,	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
binding	NULL
or	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
when	NULL
assessed	NULL
with	NULL
the	NULL
HLF	NULL
consensus	NULL
site	NULL
but	NULL
exacerbated	NULL
the	NULL
divergences	NULL
observed	NULL
on	NULL
less	NULL
preferred	NULL
sites	NULL
.	NULL

It	NULL
is	NULL
currently	NULL
unclear	NULL
whether	NULL
this	NULL
mutation	NULL
may	NULL
direct	NULL
the	NULL
E2A-HLF	NULL
chimera	NULL
away	NULL
from	NULL
or	NULL
toward	NULL
select	NULL
binding	NULL
sites	NULL
in	NULL
vivo	NULL
or	NULL
simply	NULL
was	NULL
tolerated	NULL
as	NULL
functionally	NULL
insignificant	NULL
in	NULL
the	NULL
leukemia	NULL
cells	NULL
in	NULL
which	NULL
it	NULL
arose	NULL
.	NULL

Distinguishing	NULL
between	NULL
these	NULL
two	NULL
possibilities	NULL
will	NULL
require	NULL
an	NULL
in	NULL
vitro	NULL
transformation	NULL
assay	NULL
.	NULL

The	NULL
most	NULL
dramatic	NULL
differences	NULL
between	NULL
the	NULL
transcriptional	NULL
effects	NULL
of	NULL
wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
were	NULL
observed	NULL
with	NULL
reporters	NULL
containing	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
such	NULL
as	NULL
VBP	NULL
VTG	NULL
II	NULL
sites	NULL
.	NULL

Despite	NULL
decreased	NULL
binding	NULL
to	NULL
this	NULL
site	NULL
in	NULL
EMSA	NULL
,	NULL
wild-type	NULL
HLF	NULL
and	NULL
TEF	NULL
each	NULL
activated	NULL
transcription	NULL
from	NULL
reporters	NULL
containing	NULL
concatamers	NULL
of	NULL
this	NULL
site	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
E2A-HLF	NULL
displayed	NULL
no	NULL
significant	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
in	NULL
EMSA	NULL
or	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
VTG	NULL
II	NULL
site-containing	NULL
reporters	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
using	NULL
exogenously	NULL
transfected	NULL
activator	NULL
constructs	NULL
,	NULL
we	NULL
found	NULL
that	NULL
E2A-HLF	NULL
was	NULL
capable	NULL
of	NULL
abolishing	NULL
TEF-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
VTG	NULL
II	NULL
site-containing	NULL
reporters	NULL
in	NULL
a	NULL
dominant-negative	NULL
manner	NULL
.	NULL

We	NULL
attempted	NULL
to	NULL
test	NULL
the	NULL
physiologic	NULL
significance	NULL
of	NULL
the	NULL
observed	NULL
repression	NULL
by	NULL
transfecting	NULL
VTG	NULL
II	NULL
site-containing	NULL
reporters	NULL
into	NULL
cell	NULL
lines	NULL
with	NULL
and	NULL
without	NULL
the	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
and	NULL
relying	NULL
on	NULL
endogenous	NULL
,	NULL
rather	NULL
than	NULL
exogenous	NULL
,	NULL
levels	NULL
of	NULL
EZA-HLF	NULL
for	NULL
repression	NULL
.	NULL

However	NULL
,	NULL
basal	NULL
levels	NULL
of	NULL
expression	NULL
from	NULL
both	NULL
VBP-TK-CAT	NULL
and	NULL
VBP-AP-CAT	NULL
reporters	NULL
were	NULL
virtually	NULL
undetectable	NULL
(	NULL
1	NULL
to	NULL
2	NULL
%	NULL
CAT	NULL
conversion	NULL
)	NULL
and	NULL
no	NULL
different	NULL
from	NULL
reporters	NULL
lacking	NULL
binding	NULL
sites	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
VTG	NULL
II	NULL
site-dependent	NULL
baseline	NULL
transcriptional	NULL
activation	NULL
made	NULL
it	NULL
technically	NULL
impossible	NULL
to	NULL
address	NULL
this	NULL
question	NULL
by	NULL
relying	NULL
on	NULL
endogenous	NULL
levels	NULL
of	NULL
protein	NULL
expression	NULL
.	NULL

It	NULL
should	NULL
be	NULL
emphasized	NULL
that	NULL
the	NULL
repression	NULL
observed	NULL
in	NULL
cotransfection	NULL
experiments	NULL
occurred	NULL
with	NULL
fairly	NULL
modest	NULL
ratios	NULL
of	NULL
E2A-HLF	NULL
to	NULL
TEF	NULL
(	NULL
5:1	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
gross	NULL
overexpression	NULL
of	NULL
E2A-HLF	NULL
is	NULL
not	NULL
required	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
observed	NULL
inhibition	NULL
occurred	NULL
through	NULL
sequestration	NULL
of	NULL
TEF	NULL
in	NULL
EZA-HLF-TEF	NULL
heterodimeric	NULL
complexes	NULL
that	NULL
are	NULL
significantly	NULL
impaired	NULL
in	NULL
binding	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
to	NULL
the	NULL
nonoptimal	NULL
VTG	NULL
II	NULL
site	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
,	NULL
we	NULL
found	NULL
that	NULL
while	NULL
E2A-HLF-TEF	NULL
heterodimers	NULL
bound	NULL
well	NULL
to	NULL
the	NULL
TEF	NULL
GH	NULL
and	NULL
HLF	NULL
consensus	NULL
sites	NULL
,	NULL
binding	NULL
to	NULL
the	NULL
VTG	NULL
II	NULL
site	NULL
was	NULL
barely	NULL
detectable	NULL
in	NULL
EMSA	NULL
(	NULL
12	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Although	NULL
TEF	NULL
mRNA	NULL
is	NULL
present	NULL
in	NULL
human	NULL
lymphoid	NULL
cells	NULL
,	NULL
including	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-ALL	NULL
cell	NULL
lines	NULL
(	NULL
12	NULL
)	NULL
,	NULL
it	NULL
is	NULL
currently	NULL
uncertain	NULL
whether	NULL
or	NULL
not	NULL
TEF	NULL
or	NULL
other	NULL
endogenous	NULL
proteins	NULL
are	NULL
available	NULL
for	NULL
in	NULL
vivo	NULL
dimerization	NULL
with	NULL
E2A-HLF	NULL
.	NULL

However	NULL
,	NULL
our	NULL
findings	NULL
suggest	NULL
the	NULL
potential	NULL
for	NULL
heteromeric	NULL
interactions	NULL
that	NULL
may	NULL
alter	NULL
expression	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
subordinate	NULL
genes	NULL
with	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
.	NULL

Transcriptional	NULL
differences	NULL
result	NULL
from	NULL
loss	NULL
of	NULL
an	NULL
HLF	NULL
ancillary	NULL
DNA-binding	NULL
domain	NULL
.	NULL

PAR	NULL
proteins	NULL
each	NULL
possess	NULL
an	NULL
amino-terminal	NULL
extension	NULL
of	NULL
the	NULL
basic	NULL
region	NULL
that	NULL
contains	NULL
a	NULL
highly	NULL
conserved	NULL
cluster	NULL
of	NULL
basic	NULL
amino	NULL
acids	NULL
and	NULL
the	NULL
adjacent	NULL
PAR	NULL
domain	NULL
.	NULL

Drolet	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
experimental	NULL
substitution	NULL
of	NULL
alanines	NULL
for	NULL
pairs	NULL
of	NULL
lysine	NULL
residues	NULL
within	NULL
this	NULL
cluster	NULL
substantially	NULL
altered	NULL
TEF	NULL
binding	NULL
to	NULL
a	NULL
recognition	NULL
element	NULL
in	NULL
the	NULL
prolactin	NULL
gene	NULL
promoter	NULL
,	NULL
but	NULL
not	NULL
the	NULL
GH	NULL
site	NULL
.	NULL

Our	NULL
studies	NULL
confirm	NULL
and	NULL
extend	NULL
these	NULL
observations	NULL
to	NULL
underscore	NULL
the	NULL
importance	NULL
of	NULL
regions	NULL
outside	NULL
the	NULL
classic	NULL
basic	NULL
region	NULL
for	NULL
binding	NULL
to	NULL
select	NULL
,	NULL
nonoptimal	NULL
sites	NULL
.	NULL

These	NULL
differences	NULL
were	NULL
a	NULL
consistent	NULL
feature	NULL
of	NULL
EZA-HLF	NULL
fusion	NULL
proteins	NULL
and	NULL
experimentally	NULL
truncated	NULL
HLF	NULL
constructs	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
residues	NULL
within	NULL
the	NULL
PAR	NULL
also	NULL
contribute	NULL
to	NULL
DNA	NULL
binding	NULL
,	NULL
since	NULL
restoration	NULL
of	NULL
wild-type	NULL
binding	NULL
required	NULL
both	NULL
the	NULL
PAR	NULL
and	NULL
BRE	NULL
within	NULL
the	NULL
backbone	NULL
of	NULL
the	NULL
E2A-HLF	NULL
fusion	NULL
protein	NULL
.	NULL

By	NULL
analogy	NULL
,	NULL
Jun	NULL
contains	NULL
a	NULL
functionally	NULL
similar	NULL
ancillary	NULL
DNA-binding	NULL
domain	NULL
which	NULL
is	NULL
also	NULL
located	NULL
immediately	NULL
amino	NULL
terminal	NULL
to	NULL
the	NULL
basic	NULL
region	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
PAR	NULL
,	NULL
this	NULL
region	NULL
is	NULL
proline	NULL
rich	NULL
,	NULL
but	NULL
there	NULL
is	NULL
no	NULL
obvious	NULL
structural	NULL
homology	NULL
between	NULL
Jun	NULL
and	NULL
HLF	NULL
in	NULL
this	NULL
region	NULL
.	NULL

Broad	NULL
spectrum	NULL
of	NULL
potential	NULL
E2A-HLF	NULL
target	NULL
genes	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
have	NULL
(	NULL
at	NULL
least	NULL
partially	NULL
)	NULL
defined	NULL
the	NULL
spectrum	NULL
of	NULL
sites	NULL
to	NULL
which	NULL
HLF	NULL
binds	NULL
,	NULL
the	NULL
subset	NULL
of	NULL
those	NULL
sites	NULL
bound	NULL
by	NULL
E2A-HLF	NULL
,	NULL
and	NULL
the	NULL
transcriptional	NULL
effects	NULL
of	NULL
wild-type	NULL
and	NULL
chimeric	NULL
HLF	NULL
proteins	NULL
on	NULL
reporter	NULL
genes	NULL
containing	NULL
concatamers	NULL
of	NULL
optimal	NULL
or	NULL
nonoptimal	NULL
binding	NULL
sites	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
sites	NULL
employed	NULL
in	NULL
experiments	NULL
described	NULL
herein	NULL
contained	NULL
complementary	NULL
pairs	NULL
of	NULL
thymidine	NULL
and	NULL
adenosine	NULL
nucleotides	NULL
at	NULL
positions	NULL
-4	NULL
and	NULL
-3	NULL
and	NULL
+3	NULL
and	NULL
+4	NULL
.	NULL

This	NULL
feature	NULL
is	NULL
characteristic	NULL
of	NULL
high-affinity	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
PAR	NULL
and	NULL
C/EBP	NULL
subclasses	NULL
of	NULL
bZIP	NULL
proteins	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
high-affinity	NULL
binding	NULL
sites	NULL
for	NULL
members	NULL
of	NULL
the	NULL
Fos/Jun	NULL
and	NULL
ATF/CREB	NULL
bZIP	NULL
subfamilies	NULL
do	NULL
not	NULL
contain	NULL
such	NULL
pairs	NULL
(	NULL
18	NULL
)	NULL
.	NULL

We	NULL
have	NULL
also	NULL
observed	NULL
that	NULL
both	NULL
HLF	NULL
and	NULL
EZ2ZA-HLF	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
sites	NULL
composed	NULL
of	NULL
one	NULL
PAR-	NULL
or	NULL
C/EBP	NULL
-like	NULL
half-site	NULL
and	NULL
one	NULL
Fos/Jun-	NULL
or	NULL
ATF/CREB-like	NULL
half-site	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
potential	NULL
leukemogenic	NULL
target	NULL
genes	NULL
regulated	NULL
by	NULL
the	NULL
chimera	NULL
include	NULL
not	NULL
only	NULL
cognate	NULL
targets	NULL
of	NULL
HLF	NULL
and	NULL
related	NULL
PAR	NULL
proteins	NULL
but	NULL
also	NULL
those	NULL
normally	NULL
regulated	NULL
by	NULL
other	NULL
bZIP	NULL
proteins	NULL
.	NULL

One	NULL
such	NULL
protein	NULL
to	NULL
consider	NULL
is	NULL
E4BP4	NULL
,	NULL
which	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
HLF	NULL
within	NULL
the	NULL
basic	NULL
region	NULL
and	NULL
binds	NULL
preferentially	NULL
to	NULL
a	NULL
site	NULL
,	NULL
(	NULL
G/A	NULL
)	NULL
T	NULL
(	NULL
G/T	NULL
)	NULL
A	NULL
(	NULL
C/T	NULL
)	NULL
GTAA	NULL
(	NULL
C/T	NULL
)	NULL
,	NULL
that	NULL
is	NULL
essentially	NULL
identical	NULL
to	NULL
the	NULL
HLF	NULL
consensus	NULL
site	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
EABP4	NULL
functions	NULL
experimentally	NULL
as	NULL
a	NULL
transcriptional	NULL
repressor	NULL
.	NULL

Two	NULL
additional	NULL
bZIP	NULL
chimeras	NULL
are	NULL
known	NULL
to	NULL
be	NULL
created	NULL
by	NULL
chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
malignancies-TLS-	NULL
(	NULL
FUS	NULL
)	NULL
/CHOP-10	NULL
(	NULL
9	NULL
,	NULL
31	NULL
)	NULL
and	NULL
EWS/ATF-1	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
E2A-HLF	NULL
,	NULL
each	NULL
of	NULL
these	NULL
chimeras	NULL
consists	NULL
of	NULL
a	NULL
bZIP	NULL
region	NULL
fused	NULL
to	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
structurally	NULL
related	NULL
proteins	NULL
EWS	NULL
or	NULL
TLS	NULL
(	NULL
FUS	NULL
)	NULL
that	NULL
contain	NULL
potential	NULL
transactivation	NULL
domains	NULL
.	NULL

Given	NULL
this	NULL
structural	NULL
similarity	NULL
,	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
or	NULL
not	NULL
the	NULL
transforming	NULL
properties	NULL
of	NULL
these	NULL
TRANSCRIPTIONAL	NULL
REGULATORY	NULL
PROPERTIES	NULL
OF	NULL
E2A-HLF	NULL
5995	NULL
different	NULL
bZIP	NULL
chimeras	NULL
are	NULL
mediated	NULL
by	NULL
aberrant	NULL
transcriptional	NULL
regulation	NULL
of	NULL
an	NULL
overlapping	NULL
set	NULL
of	NULL
target	NULL
genes	NULL
.	NULL

Functional	NULL
consequences	NULL
of	NULL
E2A-HLF	NULL
fusion	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
previously	NULL
that	NULL
endogenous	NULL
E2A-HLF-contain-ing	NULL
complexes	NULL
are	NULL
present	NULL
in	NULL
the	NULL
HAL-O1	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-ALL	NULL
cell	NULL
line	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Similar	NULL
complexes	NULL
are	NULL
observed	NULL
when	NULL
EMSA	NULL
is	NULL
performed	NULL
with	NULL
HAL-O1	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
HLF	NULL
consensus	NULL
site	NULL
,	NULL
and	NULL
these	NULL
complexes	NULL
comigrate	NULL
with	NULL
IVT	NULL
E2A-HLF	NULL
homodimers	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
studies	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
the	NULL
leukemogenic	NULL
effects	NULL
of	NULL
E2A-HLF	NULL
are	NULL
mediated	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
activate	NULL
transcription	NULL
of	NULL
target	NULL
genes	NULL
as	NULL
a	NULL
homodimer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
possible	NULL
heteromeric	NULL
interactions	NULL
with	NULL
potential	NULL
dominant-negative	NULL
effects	NULL
on	NULL
transcription	NULL
of	NULL
select	NULL
subordinate	NULL
genes	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
,	NULL
but	NULL
their	NULL
in	NULL
vivo	NULL
significance	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

E2A-HLF	NULL
chimeras	NULL
resulting	NULL
from	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
are	NULL
structurally	NULL
analogous	NULL
to	NULL
E2A-PBX1	NULL
proteins	NULL
in	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
-bear-ing	NULL
leukemias	NULL
(	NULL
19	NULL
,	NULL
28	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
the	NULL
amino-terminal	NULL
portion	NULL
of	NULL
EZ2A	NULL
including	NULL
its	NULL
transactivation	NULL
domains	NULL
is	NULL
fused	NULL
to	NULL
a	NULL
heterologous	NULL
DNA-binding	NULL
domain	NULL
donated	NULL
by	NULL
genes	NULL
not	NULL
normally	NULL
expressed	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

PBX1	NULL
and	NULL
closely	NULL
related	NULL
PBX2	NULL
and	NULL
PBX3	NULL
proteins	NULL
(	NULL
26	NULL
)	NULL
bind	NULL
a	NULL
specific	NULL
DNA	NULL
sequence	NULL
but	NULL
do	NULL
not	NULL
activate	NULL
reporter	NULL
genes	NULL
containing	NULL
this	NULL
site	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
E2A-PBX1	NULL
,	NULL
which	NULL
is	NULL
a	NULL
robust	NULL
activator	NULL
on	NULL
the	NULL
same	NULL
reporters	NULL
(	NULL
22	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
wild-type	NULL
PBX	NULL
proteins	NULL
are	NULL
incapable	NULL
of	NULL
transforming	NULL
NIH	NULL
3T3	NULL
cells	NULL
and	NULL
require	NULL
fusion	NULL
with	NULL
E2A	NULL
to	NULL
activate	NULL
their	NULL
oncogenic	NULL
potential	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
-induced	NULL
chimeras	NULL
appear	NULL
to	NULL
have	NULL
unique	NULL
transcriptional	NULL
regulatory	NULL
and	NULL
transforming	NULL
properties	NULL
not	NULL
possessed	NULL
by	NULL
either	NULL
of	NULL
the	NULL
constituent	NULL
wild-type	NULL
proteins	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
the	NULL
transcriptional	NULL
differences	NULL
between	NULL
HLF	NULL
and	NULL
E2A-HLF	NULL
appear	NULL
more	NULL
subtle	NULL
,	NULL
as	NULL
both	NULL
functioned	NULL
as	NULL
activators	NULL
in	NULL
our	NULL
experimental	NULL
assays	NULL
.	NULL

This	NULL
raises	NULL
the	NULL
issue	NULL
of	NULL
whether	NULL
protein	NULL
fusion	NULL
is	NULL
essential	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
oncogenic	NULL
potential	NULL
of	NULL
HLF	NULL
or	NULL
whether	NULL
wild-type	NULL
HLF	NULL
may	NULL
also	NULL
function	NULL
as	NULL
an	NULL
oncoprotein	NULL
in	NULL
the	NULL
correct	NULL
cellular	NULL
context	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
from	NULL
our	NULL
studies	NULL
whether	NULL
there	NULL
is	NULL
a	NULL
specific	NULL
role	NULL
for	NULL
the	NULL
EZ2A	NULL
transactivation	NULL
domains	NULL
as	NULL
opposed	NULL
to	NULL
others	NULL
in	NULL
conferring	NULL
oncogenic	NULL
potential	NULL
to	NULL
the	NULL
HLF	NULL
bZIP	NULL
domains	NULL
.	NULL

Establishment	NULL
of	NULL
an	NULL
in	NULL
vitro	NULL
transformation	NULL
assay	NULL
for	NULL
E2A-HLF	NULL
will	NULL
allow	NULL
an	NULL
experimental	NULL
assessment	NULL
of	NULL
these	NULL
issues	NULL
.	NULL

However	NULL
,	NULL
our	NULL
studies	NULL
have	NULL
established	NULL
the	NULL
spectrum	NULL
of	NULL
possible	NULL
transcriptional	NULL
regulatory	NULL
properties	NULL
of	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-encoded	NULL
chimeras	NULL
and	NULL
will	NULL
serve	NULL
as	NULL
a	NULL
foundation	NULL
for	NULL
future	NULL
studies	NULL
aimed	NULL
at	NULL
determining	NULL
which	NULL
of	NULL
these	NULL
properties	NULL
is	NULL
essential	NULL
for	NULL
transformation	NULL
and	NULL
to	NULL
help	NULL
identify	NULL
leukemogenic	NULL
target	NULL
genes	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
Photographic	NULL
support	NULL
was	NULL
provided	NULL
by	NULL
Phil	NULL
Verzola	NULL
.	NULL

We	NULL
thank	NULL
David	NULL
Lebrun	NULL
for	NULL
his	NULL
frequent	NULL
technical	NULL
assistance	NULL
and	NULL
advice	NULL
,	NULL
John	NULL
Burch	NULL
for	NULL
the	NULL
(	NULL
VBP	NULL
)	NULL
;	NULL
-TK-CAT	NULL
reporter	NULL
and	NULL
for	NULL
discussion	NULL
of	NULL
unpublished	NULL
results	NULL
,	NULL
Steve	NULL
Smith	NULL
for	NULL
his	NULL
generous	NULL
gift	NULL
of	NULL
the	NULL
UOC-B1	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
Dan	NULL
Drolet	NULL
and	NULL
Michael	NULL
Rosenfeld	NULL
for	NULL
the	NULL
rat	NULL
TEF	NULL
expression	NULL
vector	NULL
pET3aTEF	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
NIH	NULL
(	NULL
CA42971	NULL
)	NULL
.	NULL

S.P.H	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
National	NULL
Research	NULL
Service	NULL
Award	NULL
(	NULL
1	NULL
F32	NULL
CA	NULL
09184	NULL
)	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
.	NULL

M.L.C	NULL
.	NULL

is	NULL
a	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Abate	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
Luk	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1991	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
by	NULL
Fos	NULL
and	NULL
Jun	NULL
in	NULL
vitro	NULL
:	NULL
Interaction	NULL
among	NULL
multiple	NULL
activator	NULL
and	NULL
regulatory	NULL
domains	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:3624-3632	NULL
.	NULL

2	NULL
.	NULL

Aronheim	NULL
,	NULL
A.	NULL
,	NULL
R.	NULL
Shiran	NULL
,	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Walker	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
E2A	NULL
gene	NULL
product	NULL
contains	NULL
two	NULL
separable	NULL
and	NULL
functionally	NULL
distinct	NULL
transcription	NULL
activation	NULL
domains	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:8063-8067	NULL
.	NULL

5996	NULL
3	NULL
.	NULL

10	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

20	NULL
.	NULL

HUNGER	NULL
ET	NULL
AL	NULL
.	NULL

Barr	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
N.	NULL
Galili	NULL
,	NULL
J.	NULL
Holick	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Biegel	NULL
,	NULL
G.	NULL
Rovera	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
Emmanuel	NULL
.	NULL

1993	NULL
.	NULL

Rearrangement	NULL
of	NULL
the	NULL
PAX3	NULL
paired	NULL
box	NULL
gene	NULL
in	NULL
the	NULL
paediatric	NULL
solid	NULL
tumour	NULL
alveolar	NULL
rhabdomyosarcoma	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

3:113-117.	NULL
.	NULL

Blackwell	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1990	NULL
.	NULL

Differences	NULL
and	NULL
simi-	NULL
larities	NULL
in	NULL
DNA-binding	NULL
preferences	NULL
of	NULL
MyoD	NULL
and	NULL
E2A	NULL
protein	NULL
complexes	NULL
revealed	NULL
by	NULL
binding	NULL
site	NULL
selection	NULL
.	NULL

Science	NULL
250:1104-1110.	NULL
.	NULL

Burk	NULL
,	NULL
O.	NULL
,	NULL
S.	NULL
Mink	NULL
,	NULL
M.	NULL
Ringwald	NULL
,	NULL
and	NULL
K.-H.	NULL
Klempnauer	NULL
.	NULL

1993	NULL
.	NULL

Synergistic	NULL
activation	NULL
of	NULL
the	NULL
chicken	NULL
mim-/	NULL
gene	NULL
by	NULL
v-myb	NULL
and	NULL
C/EBP	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:2027-2038.	NULL
.	NULL

Cleary	NULL
,	NULL
M.	NULL
L	NULL
,	NULL
1991	NULL
.	NULL

Oncogenic	NULL
conversion	NULL
of	NULL
transcription	NULL
factors	NULL
by	NULL
chromosomal	NULL
translocations	NULL
.	NULL

Cell	NULL
66:619-622.	NULL
.	NULL

Cooper	NULL
,	NULL
C.	NULL
,	NULL
D.	NULL
Johnson	NULL
,	NULL
C.	NULL
Roman	NULL
,	NULL
N.	NULL
Avitahl	NULL
,	NULL
P.	NULL
Tucker	NULL
,	NULL
and	NULL
K.	NULL
Calame	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
C/EBP	NULL
family	NULL
of	NULL
transcriptional	NULL
activators	NULL
is	NULL
functionally	NULL
important	NULL
for	NULL
V	NULL
,	NULL
,	NULL
promoter	NULL
activity	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:3225-3231.	NULL
.	NULL

Cowell	NULL
,	NULL
I.	NULL
G.	NULL
,	NULL
A.	NULL
Skinner	NULL
,	NULL
and	NULL
H.	NULL
C.	NULL
Hurst	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
repression	NULL
by	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
bZIP	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3070-3077.	NULL
.	NULL

Crozat	NULL
,	NULL
A.	NULL
,	NULL
P.	NULL
Aman	NULL
,	NULL
N.	NULL
Mandahl	NULL
,	NULL
and	NULL
D.	NULL
Ron	NULL
.	NULL

1993	NULL
.	NULL

Fusion	NULL
of	NULL
CHOP	NULL
to	NULL
a	NULL
novel	NULL
RNA-binding	NULL
protein	NULL
in	NULL
human	NULL
myxoid	NULL
liposarcoma	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
363:640-644	NULL
.	NULL

Curran	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
P.	NULL
K.	NULL
Vogt	NULL
.	NULL

1992	NULL
.	NULL

Dangerous	NULL
liaisons	NULL
:	NULL
fos	NULL
and	NULL
jun	NULL
,	NULL
oncogenic	NULL
transcription	NULL
factors	NULL
,	NULL
p.	NULL
797-832	NULL
.	NULL

In	NULL
S.	NULL
L.	NULL
McKnight	NULL
and	NULL
K.	NULL
Yamamoto	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Transcriptional	NULL
regulation	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
.	NULL

Drolet	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
K.	NULL
M.	NULL
Scully	NULL
,	NULL
D.	NULL
M.	NULL
Simmons	NULL
,	NULL
M.	NULL
Wegner	NULL
,	NULL
K.	NULL
Chu	NULL
,	NULL
L.	NULL
W.	NULL
Swanson	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1991	NULL
.	NULL

TEF	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
expressed	NULL
specifically	NULL
in	NULL
the	NULL
anterior	NULL
pituitary	NULL
during	NULL
em-bryogenesis	NULL
,	NULL
defines	NULL
a	NULL
new	NULL
class	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:1739-1753	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
P.	NULL
E.	NULL
Devaraj	NULL
,	NULL
L.	NULL
Foroni	NULL
,	NULL
L.	NULL
M.	NULL
Secker-Walker	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
genomic	NULL
rearrangements	NULL
create	NULL
alternative	NULL
E2ZA-HLF	NULL
fusion	NULL
proteins	NULL
in	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
-ALL	NULL
.	NULL

Blood	NULL
83:2970-2977	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
N.	NULL
Galili	NULL
,	NULL
A.	NULL
J.	NULL
Carroll	NULL
,	NULL
W.	NULL
M.	NULL
Crist	NULL
,	NULL
M.	NULL
P.	NULL
Link	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q23	NULL
;	NULL
p13	NULL
)	NULL
results	NULL
in	NULL
consistent	NULL
fusion	NULL
of	NULL
£24	NULL
and	NULL
PBXT	NULL
coding	NULL
sequences	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemias	NULL
.	NULL

Blood	NULL
77:687-693	NULL
.	NULL

Hunger	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
K.	NULL
Ohyashiki	NULL
,	NULL
K.	NULL
Toyama	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1992	NULL
.	NULL

HLF	NULL
,	NULL
a	NULL
novel	NULL
hepatic	NULL
bZIP	NULL
protein	NULL
,	NULL
shows	NULL
altered	NULL
DNA-binding	NULL
properties	NULL
following	NULL
fusion	NULL
to	NULL
E2A	NULL
in	NULL
t	NULL
(	NULL
17	NULL
;	NULL
19	NULL
)	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1608-1620	NULL
.	NULL

Inaba	NULL
,	NULL
T.	NULL
,	NULL
W.	NULL
M.	NULL
Roberts	NULL
,	NULL
L.	NULL
H.	NULL
Shapiro	NULL
,	NULL
K.	NULL
W.	NULL
Jolly	NULL
,	NULL
S.	NULL
C.	NULL
Raimondi	NULL
,	NULL
S.	NULL
D.	NULL
Smith	NULL
,	NULL
and	NULL
A.	NULL
T.	NULL
Look	NULL
.	NULL

1992	NULL
.	NULL

Fusion	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
gene	NULL
HLF	NULL
to	NULL
the	NULL
E24	NULL
gene	NULL
in	NULL
human	NULL
acute	NULL
B-lineage	NULL
leukemia	NULL
.	NULL

Science	NULL
257:531-534	NULL
.	NULL

Iyer	NULL
,	NULL
S.	NULL
V.	NULL
,	NULL
D.	NULL
L.	NULL
Davis	NULL
,	NULL
S.	NULL
N.	NULL
Sea	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Burch	NULL
.	NULL

1991	NULL
.	NULL

Chicken	NULL
vitellogenin	NULL
gene-binding	NULL
protein	NULL
,	NULL
a	NULL
leucine	NULL
zipper	NULL
transcription	NULL
factor	NULL
that	NULL
binds	NULL
to	NULL
an	NULL
important	NULL
control	NULL
element	NULL
in	NULL
the	NULL
chicken	NULL
vitellogenin	NULL
II	NULL
promoter	NULL
,	NULL
is	NULL
related	NULL
to	NULL
rat	NULL
DBP	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:4863-4875	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
1993	NULL
.	NULL

Identification	NULL
of	NULL
C/EBP	NULL
basic	NULL
region	NULL
residues	NULL
involved	NULL
in	NULL
DNA	NULL
sequence	NULL
recognition	NULL
and	NULL
half-site	NULL
spacing	NULL
preference	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6919-6930.	NULL
.	NULL

Kamps	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
C.	NULL
M.	NULL
Murre	NULL
,	NULL
X.-H.	NULL
Sun	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
new	NULL
homeobox	NULL
gene	NULL
contributes	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
translocation	NULL
protein	NULL
in	NULL
pre-B	NULL
ALL	NULL
.	NULL

Cell	NULL
60:547-555	NULL
.	NULL

Katz	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
Kowenz-Leutz	NULL
,	NULL
C.	NULL
Muller	NULL
,	NULL
K.	NULL
Meese	NULL
,	NULL
S.	NULL
A.	NULL
Ness	NULL
,	NULL
and	NULL
A.	NULL
Leutz	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NF-M	NULL
transcription	NULL
factor	NULL
is	NULL
related	NULL
to	NULL
C/EBPB	NULL
and	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
signal	NULL
transduction	NULL
,	NULL
differentiation	NULL
and	NULL
leuka-	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

mogenesis	NULL
of	NULL
avian	NULL
myelomonocytic	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:1321-1332	NULL
.	NULL

Lavery	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1993	NULL
.	NULL

Circadian	NULL
transcription	NULL
of	NULL
the	NULL
cholesterol	NULL
7a	NULL
hydroxylase	NULL
gene	NULL
may	NULL
involve	NULL
the	NULL
liver-enriched	NULL
bZIP	NULL
protein	NULL
DBP	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1871-1884	NULL
.	NULL

Lebrun	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1994	NULL
.	NULL

Fusion	NULL
with	NULL
E2A	NULL
alters	NULL
the	NULL
transcriptional	NULL
properties	NULL
of	NULL
the	NULL
homeodomain	NULL
protein	NULL
PBX1	NULL
in	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
leukemias	NULL
.	NULL

Oncogene	NULL
9:1641-1647	NULL
.	NULL

Luckow	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
G.	NULL
Schiitz	NULL
.	NULL

1987	NULL
.	NULL

CAT	NULL
constructions	NULL
with	NULL
multiple	NULL
unique	NULL
restriction	NULL
sites	NULL
for	NULL
the	NULL
functional	NULL
analysis	NULL
of	NULL
eukaryotic	NULL
promoters	NULL
and	NULL
regulatory	NULL
elements	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15:5490	NULL
.	NULL

May	NULL
,	NULL
W.	NULL
A.	NULL
,	NULL
M.	NULL
L.	NULL
Gishizky	NULL
,	NULL
S.	NULL
L.	NULL
Lessnick	NULL
,	NULL
L.	NULL
B.	NULL
Lunsford	NULL
,	NULL
B.	NULL
C.	NULL
Lewis	NULL
,	NULL
O.	NULL
Delattre	NULL
,	NULL
J.	NULL
Zucman	NULL
,	NULL
G.	NULL
Thomas	NULL
,	NULL
and	NULL
C.	NULL
T.	NULL
Denny	NULL
.	NULL

1993	NULL
.	NULL

Ewing	NULL
sarcoma	NULL
11	NULL
;	NULL
22	NULL
translocation	NULL
produces	NULL
a	NULL
chimeric	NULL
transcription	NULL
factor	NULL
that	NULL
requires	NULL
the	NULL
DNA-binding	NULL
domain	NULL
encoded	NULL
by	NULL
FLI1	NULL
for	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:5752-5756	NULL
.	NULL

Monica	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Monica	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
Galili	NULL
,	NULL
J.	NULL
Nourse	NULL
,	NULL
D.	NULL
Saltman	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1991	NULL
.	NULL

PBX2	NULL
and	NULL
PBX3	NULL
,	NULL
new	NULL
homeobox	NULL
genes	NULL
with	NULL
extensive	NULL
homology	NULL
to	NULL
the	NULL
human	NULL
proto-oncogene	NULL
PBX7	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:6149-6157	NULL
.	NULL

Mueller	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
P.	NULL
Maire	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1990	NULL
.	NULL

DBP	NULL
,	NULL
a	NULL
liver-enriched	NULL
transcriptional	NULL
activator	NULL
,	NULL
is	NULL
expressed	NULL
late	NULL
in	NULL
ontogeny	NULL
and	NULL
its	NULL
tissue	NULL
specificity	NULL
is	NULL
determined	NULL
posttranscriptionally	NULL
.	NULL

Cell	NULL
61:279-291	NULL
.	NULL

Nourse	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
D.	NULL
Mellentin	NULL
,	NULL
N.	NULL
Galili	NULL
,	NULL
J.	NULL
Wilkinson	NULL
,	NULL
E.	NULL
Stanbridge	NULL
,	NULL
S.	NULL
D.	NULL
Smith	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Cleary	NULL
.	NULL

1990	NULL
.	NULL

Chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
1	NULL
;	NULL
19	NULL
)	NULL
results	NULL
in	NULL
synthesis	NULL
of	NULL
a	NULL
homeobox	NULL
fusion	NULL
mRNA	NULL
that	NULL
codes	NULL
for	NULL
a	NULL
potential	NULL
chimeric	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
60:535-545	NULL
.	NULL

Picketts	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
D.	NULL
P.	NULL
Lillicrap	NULL
,	NULL
and	NULL
C.	NULL
R.	NULL
Mueller	NULL
.	NULL

1993	NULL
.	NULL

Synergy	NULL
between	NULL
transcription	NULL
factors	NULL
DBP	NULL
and	NULL
C/EBP	NULL
compensates	NULL
for	NULL
a	NULL
haemophilia	NULL
B	NULL
Leyden	NULL
factor	NULL
IX	NULL
mutation	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

3:175-179	NULL
.	NULL

Quong	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
M.	NULL
E.	NULL
Massari	NULL
,	NULL
R.	NULL
Zwant	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
new	NULL
transcriptional	NULL
activation	NULL
motif	NULL
restricted	NULL
to	NULL
a	NULL
class	NULL
of	NULL
helix-loop-helix	NULL
proteins	NULL
is	NULL
functionally	NULL
conserved	NULL
in	NULL
both	NULL
yeast	NULL
and	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:792-800	NULL
.	NULL

Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
A.	NULL
Forster	NULL
,	NULL
R.	NULL
Larson	NULL
,	NULL
and	NULL
P.	NULL
Nathan	NULL
.	NULL

1993	NULL
.	NULL

Fusion	NULL
of	NULL
the	NULL
dominant	NULL
negative	NULL
transcription	NULL
regulator	NULL
CHOP	NULL
with	NULL
a	NULL
novel	NULL
gene	NULL
FUS	NULL
by	NULL
translocation	NULL
t	NULL
(	NULL
12	NULL
;	NULL
16	NULL
)	NULL
in	NULL
malignant	NULL
liposarcoma	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

4:174-180	NULL
.	NULL

Van	NULL
Dijk	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
M.	NULL
Voorhoeve	NULL
,	NULL
and	NULL
C.	NULL
Murre	NULL
.	NULL

1993	NULL
.	NULL

Pbx1	NULL
is	NULL
converted	NULL
into	NULL
a	NULL
transcriptional	NULL
activator	NULL
upon	NULL
acquiring	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
E2A	NULL
in	NULL
pre-B-cell	NULL
acute	NULL
lymphoblastoid	NULL
leukemia	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:6061-6065	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
T.	NULL
Hai	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Boyd	NULL
.	NULL

1993	NULL
.	NULL

Dimerization	NULL
specificity	NULL
of	NULL
the	NULL
leucine	NULL
zipper-containing	NULL
bZIP	NULL
motif	NULL
on	NULL
DNA	NULL
binding	NULL
:	NULL
prediction	NULL
and	NULL
rational	NULL
design	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:1047-1058	NULL
.	NULL

Vinson	NULL
,	NULL
C.	NULL
R.	NULL
,	NULL
P.	NULL
B.	NULL
Sigler	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Scissors	NULL
grip	NULL
model	NULL
for	NULL
DNA	NULL
recognition	NULL
by	NULL
a	NULL
family	NULL
of	NULL
leucine	NULL
zipper	NULL
proteins	NULL
.	NULL

Science	NULL
246:911-916	NULL
.	NULL

Wuarin	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
U.	NULL
Schibler	NULL
.	NULL

1990	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
liver-enriched	NULL
transcriptional	NULL
activator	NULL
DBP	NULL
follows	NULL
a	NULL
stringent	NULL
circadian	NULL
rhythm	NULL
.	NULL

Cell	NULL
63:1257-1266	NULL
.	NULL

Yano	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
Falver	NULL
,	NULL
and	NULL
F.	NULL
J.	NULL
Gonzalez	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
liver-enriched	NULL
transcription	NULL
factor	NULL
DBP	NULL
in	NULL
expression	NULL
of	NULL
the	NULL
cyto-chrome	NULL
P450	NULL
CYP2C6	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:2847-2854	NULL
.	NULL

Yanofsky	NULL
,	NULL
C.	NULL
1992	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
:	NULL
elegance	NULL
in	NULL
design	NULL
and	NULL
discovery	NULL
,	NULL
p.	NULL
3-26	NULL
.	NULL

In	NULL
S.	NULL
L.	NULL
McKnight	NULL
and	NULL
K.	NULL
Yamamoto	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Transcriptional	NULL
regulation	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Zucman	NULL
,	NULL
J.	NULL
,	NULL
O.	NULL
Delattre	NULL
,	NULL
and	NULL
C.	NULL
Desmaze	NULL
.	NULL

1993	NULL
.	NULL

EWS	NULL
and	NULL
ATF-/	NULL
gene	NULL
fusion	NULL
induced	NULL
by	NULL
t	NULL
(	NULL
12	NULL
;	NULL
22	NULL
)	NULL
translocation	NULL
in	NULL
malignant	NULL
melanoma	NULL
of	NULL
soft	NULL
parts	NULL
.	NULL

Nat	NULL
.	NULL

Genet	NULL
.	NULL

4:341	NULL
.	NULL

